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A B S T R A C T
Background
A number of conditions compromise the passage of food along the digestive tract. Nasogastric tube (NGT) feeding is a classic, time-
proven technique, although its prolonged use can lead to complications such as lesions to the nasal wing, chronic sinusitis, gastro-
oesophageal reflux, and aspiration pneumonia. Another method of infusion, percutaneous endoscopy gastrostomy (PEG), is generally
used when there is a need for enteral nutrition for a longer time period. There is a high demand for PEG in patients with swallowing
disorders, although there is no consistent evidence about its effectiveness and safety as compared to NGT.
Objectives
To evaluate the effectiveness and safety of PEG compared with NGT for adults with swallowing disturbances.
Search methods
We searched The Cochrane Library, MEDLINE, EMBASE, and LILACS from inception to January 2014, and contacted the main
authors in the subject area. There was no language restriction in the search.
Selection criteria
We planned to include randomised controlled trials comparing PEG versus NGT for adults with swallowing disturbances or dysphagia
and indications for nutritional support, with any underlying diseases. The primary outcome was intervention failure (e.g. feeding
interruption, blocking or leakage of the tube, no adherence to treatment).
Data collection and analysis
We used standard methodological procedures expected by The Cochrane Collaboration. For dichotomous and continuous variables,
we used risk ratio (RR) and mean difference (MD), respectively with the random-effects statistical model and 95% confidence interval
(CI). We assumed statistical heterogeneity when I² > 50%.
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Main results
We included 11 randomised controlled studies with 735 participants which produced 16 meta-analyses of outcome data. Meta-analysis
indicated that the primary outcome of intervention failure, occurred in lower proportion of participants with PEG compared to NGT
(RR 0.18, 95% CI 0.05 to 0.59, eight studies, 408 participants, low quality evidence) and this difference was statistically significant. For
this outcome, we also subgrouped the studies by endoscopic gastrostomy technique into pull, and push and not reported. We observed
a significant difference favouring PEG in the pull subgroup (RR 0.07, 95% CI 0.01 to 0.35, three studies, 90 participants). Thepush
subgroup contained only one clinical trial and the result favoured PEG (RR 0.05, 95% CI 0.00 to 0.74, one study, 33 participants)
techniques. We found no statistically significant difference in cases where the technique was not reported (RR 0.43, 95% CI 0.13 to
1.44, four studies, 285 participants).
There was no statistically significant difference between the groups for meta-analyses of the secondary outcomes of mortality (RR 0.86,
95% CI 0.58 to 1.28, 644 participants, nine studies, very low quality evidence), overall reports of any adverse event at any follow-up
time point (ITT analysis, RR 0.83, 95% CI 0.51 to 1.34), 597 participants, 6 studies, moderate quality evidence), specific adverse events
including pneumonia (aspiration) (RR 0.70, 95% CI 0.46 to 1.06, 645 participants, seven studies, low quality evidence), or for the
meta- analyses of the secondary outcome of nutritional status including weight change from baseline, and mid-arm circumference at
endpoint, although there was evidence in favour of PEG for meta-analyses of mid-arm circumference change from baseline (MD 1.16,
95% CI 1.01 to 1.31, 115 participants, two studies), and levels of serum albumin were higher in the PEG group (MD 6.03, 95% CI
2.31 to 9.74, 107 participants).
For meta-analyses of the secondary outcomes of time on enteral nutrition, there was no statistically significant difference (MD 14.48,
95% CI -2.74 to 31.71; 119 participants, two studies). For meta-analyses of quality of life measures (EuroQol) outcomes in two studies
with 133 participants, for inconvenience (RR 0.03, 95% CI 0.00 to 0.29), discomfort (RR 0.03, 95% CI 0.00 to 0.29), altered body
image (RR 0.01, 95% CI 0.00 to 0.18; P = 0.001) and social activities (RR 0.01, 95% CI 0.00 to 0.18) the intervention favoured
PEG, that is, fewer participants found the intervention of PEG to be inconvenient, uncomfortable or interfered with social activities.
However, there were no significant differences between the groups for pain, ease of learning to use, or the secondary outcome of length
of hospital stay (two studies, 381 participants).
Authors’ conclusions
PEG was associated with a lower probability of intervention failure, suggesting the endoscopic procedure may be more effective and safe
compared with NGT. There is no significant difference in mortality rates between comparison groups, or in adverse events, including
pneumonia related to aspiration. Future studies should include details of participant demographics including underlying disease, age
and gender, and the gastrostomy technique.
P L A I N L A N G U A G E S U M M A R Y
Nutritional support for adults with swallowing difficulties
Background
A number of conditions compromise the transport of food along the digestive tract. Patients with swallowing disturbances can develop
low nutritional status, which affects their recovery from illness, surgery, and injury. Conditions associated with swallowing disorders
include stroke, neurological diseases, dementia, cancers of the head and neck, amyotrophic lateral sclerosis, physical obstruction, and
dysphagia from stroke. Nasogastric tube feeding is a time proven technique to provide nutritional support; the tube can be inserted by
a nurse. Percutaneous endoscopy gastrostomy (PEG) involves a feeding tube inserted directly into the stomach through the abdomen
and is particularly useful when enteral nutrition is needed for a length of time.
Review question
Prolonged use of a nasal tube can lead to adverse events such as damage to the nose and larynx, chronic sinusitis, gastro-oesophageal
reflux, and aspiration pneumonia (which can result from inhalation of stomach contents leading to lower respiratory tract infection
and pneumonia).
Study characteristics
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We obtained updated evidence for this review from 11 randomised controlled studies comparing a nasogastric tube with PEG in a
total of 735 patients. Seven studies measured treatment failure i.e. feeding interruption, blocking or leakage of the feeding tube in 408
patients randomised to either a nasal gastric tube or PEG.
Key results
The studies showed a higher probability of treatment failure with a nasal gastric tube. The number of deaths was no different with the
two methods; nor was the overall occurrence of adverse events. Participants with PEGs may have a better quality of life.
Quality of the evidence
Possible limitations of this review include the small number of participants in the majority of studies, explained by the high cost of
PEG and requirements for endoscopy in its use, the operational challenges to accomplish a clinical trial in this area and the different
length of follow-up of the patients in the studies (from less than four weeks to six months). There were clinical differences between
the trials, with the participants having different baseline diseases and different techniques used to insert the PEG. The findings of
the present review of the literature should be interpreted with caution, given that there were methodological issues with most of the
included studies which increase the risk of bias in the trial. This systematic review of the literature is valuable in analysing 11 studies,
with a sample size of 735 patients. Nevertheless, further randomised clinical trials that adopt a rigorous method are warranted.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Percutaneous endoscopic gastrostomy compared with nasogastric tube feeding for adults with swallowing disturbances
Patient or population: adult patients with swallowing disturbances
Settings: in-patient
Intervention: percutaneous endoscopic gastrostomy
Comparison: nasogastric tube feeding
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Nasogastric tube feed-
ing
Percutaneous
endoscopic gastrostomy
Treatment failure
Feeding interruption,
blocking or leakage of the
tube, non-adherence
Follow-up: 0 to 6 months
Study population RR 0.18
(0.05 to 0.59)
408
(8 studies)
⊕⊕©©
low1,3
The subgroup of stroke/
neurological
diseases was associated
with a lower risk of inter-
vention failure compared
with the subgroup com-
posed of mixed diseases
Favours PEG
391 per 1000 70 per 1000
(20 to 231)
Low
375 per 1000 30 per 1000
(7 to 124)
High
319 per 1000 102 per 1000
(26 to 421)
Mortality irrespective of
follow-up time
Follow-up: 0 to 6 months
366 per 1000 315 per 1000
(212 to 469)
RR 0.86
(0.58 to 1.28)
644
(9 studies)
⊕©©©
very low1,2,3
Favours neither PEG nor
NGT.
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Pneumonia irrespective
of follow-up time
Follow-up: 0 to 6 months
415 per 1000 291 per 1000
(24 to 45)
RR 0.7
(0.46 to 1.06)
645
(7 studies)
⊕⊕©©
low1,3
Favours neither PEG nor
NGT.
Adverse events irre-
spective of follow-up
time
Follow-up: 0-17 months
458 per 1000 380 per 1000
(234 to 614)
RR 0.83
(0.51 to 1.34)
597
(6 studies)
⊕⊕⊕©
moderate1,3
Favours neither PEG nor
NGT.
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Design limitation (risk of bias), unclear sequence generation, allocation concealment and loss to follow-up.
2 Relatively few participants and few events and/or wide confidence intervals
3 Widely differing estimates of the treatment effect (i.e. heterogeneity or variability in results) across studies
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B A C K G R O U N D
A number of conditions compromise the passage of food along
the digestive tract. Disturbances may be due to blockage, as seen
in stenosis and cancer of the stomach or larynx, or due to swal-
lowing difficulties such as in genetic diseases, stroke sequelae, cra-
nial encephalic trauma, brain tumours, and amyotrophic lateral
sclerosis (Heemskerk 2014; Löser 2005; Piecuch 2013; Schneider
2014). Several approaches are available to provide nutritional sup-
port (Nugent 2013). Nasogastric tube (NGT) feeding is a classic,
time-proven technique, although its prolonged use can lead to ad-
verse events such as lesions to the nasal wing, chronic sinusitis, gas-
tro-oesophageal reflux, and aspiration pneumonia (Bastow 1986;
Beavan 2010). Two meta-analyses comparing tube placement into
the stomach or duodenum revealed no significant difference be-
tween the methods in terms of length of hospital stay, mortality,
or adverse events (Ho 2006; Marik 2003). In addition to adverse
events, the need to change the tube due to blockage inherent to
its narrow gauge coupled with its disagreeable appearance in social
settings have led to the election of alternative techniques whenever
possible (Zaherah 2012).
Gastrostomy has been used to gain access to the stomach for long-
term enteral feeding in patients with swallowing limitations who
require nutritional support. The main criteria for indicating gas-
trostomy are (i) a reasonable prospect of patient survival and (ii)
normal intestinal function (Friginal-Ruiz 2011). This surgical pro-
cedure was first carried out successfully in humans in 1876, by
Verneuil in France. Following various modifications, Stamm de-
vised the technique most frequently used to this day (Ljungdahl
2006). In 1980, Gauderer et al described a new technique of feed-
ing tube placement in gastrostomy using endoscopy, called per-
cutaneous endoscopic gastrostomy (PEG). This involves a local
anaesthetic and does not require laparotomy (Gauderer 1980).
Since the introduction of PEG, a number of studies comparing
methods of gastrostomy have been conducted, such as operative,
push and pull PEG techniques (Köhler 2014; Stiegmann 1990;
Tucker 2003).
Previous systematic reviews andmeta-analyses on enteral nutrition
approaches have been performed, but not with the broad scope
we propose. Langmore 2006 published a meta-analysis that inves-
tigated enteral nutrition, specifically in amyotrophic lateral scle-
rosis, comparing the use of several types of feeding tubes in pa-
tients being fed orally. However, they did not find any controlled
or randomised studies. Another meta-analysis compared nutrition
by endoscopic gastrostomy and NGT including only post-stroke
patients (Bath 1999). Thereafter, a number of controlled and ran-
domised studies were published that compared the two methods
of nutritional support in stroke patients and those admitted to
intensive care units with a range of different pathologies, as well
as individuals on mechanical ventilation (Dennis 2005; Douzinas
2006; Hamidon 2006; McClave 2005).
Assessment of these latest studies in patients with a range of
pathologies, together with analysis of the optimalmoment to com-
mence nutritional support, warrant mapping by means of a sys-
tematic review so as to offer the best evidence available on which
to base decisions.
Description of the condition
Malnutrition encompasses overnutrition and undernutrition, but
undernutrition is a prevalent, and undesired condition affecting
up to 40% of hospitalised patients (Barker 2011). This condition
has important causal associations with morbidity and mortality,
by affecting, for example, length of stay in hospital; recovery from
illness, surgery and injury; cardiac function, weakmuscles (includ-
ing respiratory muscles), with consequent higher risk of throm-
boembolism, chest infection, and pressure sores (Geeganage 2012;
Iwamoto 2014; Löser 2010; Pearce 2002; Valente da Silva 2012).
Mortality rates tend to be higher in elderly and undernourished
patients in comparison to other subgroups of hospitalised patients
(Ordoñez 2013; Valente da Silva 2012). In this sense, swallowing
disturbances are of special interest, because of its direct relation-
ship with undernutrition (Poisson 2014).
The clinical diagnosis of swallowing disturbances can be given
based on clinical signals such as delay in swallowing, pharyngeal
sensibility, abnormality or absence of tongue movements; loos-
ening of water from lips, pocketing of food in the cheek, under
the tongue or on the hard palate, coughing or choking while eat-
ing or signs of penetration or aspiration (Falsetti 2009; Simons
2014). Although not usually used in daily practice, radiological
tests like videofluoroscopic modified barium swallow and vide-
ofluoroscopic swallowing study can be used for diagnosis of dys-
phagia (Finestone 2003; Scheeren 2014; Stec 2008).
Patients with indications for enteral nutrition (nutrients intake
by means of feeding tubes) include those with conditions asso-
ciated with swallowing disorders, such as motor neuron disease
and multiple sclerosis; physical obstruction to swallowing, such
as oesophageal tumours; an inability to ingest food due to head
injury or stroke; and those with anorexia due to an underlying dis-
ease such as chronic lung disease, irritable bowel disease, or cancer
(Botella Romero 2012; de Aguilar-Nascimento 2011; Fini 2014;
Kola ek 2013; Manba 2014). Dysphagic patients and those with
anorexia, malabsorption, or excessive catabolism also may need
long-term enteral feeding (Le 2010; Gentile 2012; Pearce 2002).
Aspiration risk often is an indication for nutritional support using
tubes (Corry 2008; Metheny 2010). Enteral nutrition can be pro-
vided in the form of drink supplements or, if a patient is unable
to take adequate nutritional supplements orally, fed via an enteral
tube into the stomach or small bowel (Granell Vidal 2014; Löser
2005).
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Description of the intervention
In general, tube systems for artificial enteral nutrition can be posi-
tioned by nasal insertion, guided percutaneous application, or sur-
gical techniques (Abdel-Lah Mohamed 2006; Blumenstein 2014;
Gopalan 2003; Schröder 2004). The superiority of percutaneously
placed gastrostomies compared with the former surgical gastros-
tomy procedures (that is, Witzel, Stamm, Janeway techniques)
has been clearly suggested (Löser 2005; Ljungdahl 2006). Lower
complication rates, reduced hospital length of stay and costs have
been reported (Grant 1988; Ljungdahl 2006). Most patients who
require nutritional support need it for around one month or less,
with the nasogastric sound probe being the main way of infu-
sion (Blumenstein 2014; Pearce 2002). The probe used is made
of thin polyurethane, size 14 with an internal diameter of 3.3
mm, and is inserted by a trained professional in order to prevent
adverse events such as perforation and tracheobronchial location
(Hamidon 2006; Löser 2005). Another method of infusion, per-
cutaneous endoscopy gastrostomy (PEG), is generally used when
there is a need for enteral nutrition for a longer time period (Löser
2005; Pearce 2002). This procedure can be done by either ’pull’ or
’push’ techniques, the former being simpler and more frequently
used. Both techniques use a silicon probe (for example 24 Fr, in-
ternal diameter 5.5 mm). The puncture site is marked with gas-
troscopic monitoring of the anterior gastric wall in the region of
the distal corpus, after adequate local anaesthesia and intravenous
sedation (Hamidon 2006; Löser 2005). Prospective studies have
shown that the early insertion of the probe via PEG improves the
patient’s nutritional state (Hamidon 2006;Norton1996). Patients
treated for head and neck carcinoma have considered PEG to be
more acceptable than a NGT, even though persistent dysphagia
was associated with PEG (Mekhail 2001). A cohort study verified
the acceptability of PEG, with significantly higher survival time
and lower aspiration rates (Dwolatzky 2001) compared to NGT.
On the other hand, a narrative review (Plonk 2005) reported in-
creased risk of death in stroke patients with PEG compared with
NGT and concluded that aspiration pneumonia rates were simi-
lar. Published guidelines on enteral nutrition recommend the per-
forming of gastrostomy, preferably endoscopically (Löser 2005).
Radiologically placed gastrostomy (RIG) is another method of
enteral nutrition, but operationally different from PEG. RIG is
not an endoscopic procedure and utilises fluoroscopy, performed
in an interventional radiologic suite (Barkmeier 1998;Chiò2004).
How the intervention might work
The percutaneous gastronomy probe is of a larger calibre com-
pared with an NGT and is placed in the abdomen. This leads
to less interruption of nutrition caused by the probe being with-
drawn as well as reduced reflux with consequent aspiration, thus
being less embarrassing for the patient (Dwolatzky 2001; Pearce
2002). Patients and carers believe that nutrition via PEG helps in
feeding and the ability to cope, being more convenient than NGT
(Anis 2006). PEG-related morbidity and mortality are 9.4% and
0.53%, respectively (Wollman 1995). There are, however, exclu-
sive adverse events for endoscopy percutaneous gastrostomy, such
as peritonitis, buried bumper syndrome, gastrocolocutaneous fis-
tula, and wound infection (Potack 2008). Adverse events associ-
ated with NGTdue to its nasogastric insertion and positioning are
also cited, including sinusitis, laryngeal ulcerations, pneumotho-
rax, and tracheoesophagic fistula; the latter due to incorrect posi-
tioning of the tube (Pearce 2002).
Why it is important to do this review
According to Potack 2008, there is a high demand for PEG in pa-
tients with swallowing disorders, with 160,000 to 200,000 PEG
procedures performed per year in the USA. This makes PEG the
procedure of choice for nutritional support in adults. The same
author commented that many such procedures are performed, al-
though there is no consistent evidence about what is the more
effective and safe method. Because NGT and PEG are the most
commonly used methods for feeding access (Pearce 2002), a sys-
tematic review is worth performing to resolve such questions.
O B J E C T I V E S
Toevaluate the effectiveness and safety of percutaneous endoscopic
gastrostomy (PEG) as compared to a nasogastric tube (NGT) for
adults with swallowing disturbances, by updating our previous
Cochrane review (Other published versions of this review), assess-
ing the included studies with the revised ’Risk of bias’ assessments,
and to assess the overall level of evidence using the GRADE ap-
proach.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials comparing percutaneous endoscopic
gastrostomy (PEG) versus nasogastric tube (NGT) for nutrition
in adults with swallowing disturbances.
Types of participants
Adult patients presenting with swallowing disturbances or dys-
phagia and indications for nutritional support, as identified by the
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authors of primary studies. Patients with any underlying diseases
were also acceptable.
Types of interventions
The comparison arms of interest are as follows.
• Intervention group: PEG performed by any method (e.g.,
pull and push methods, others).
• Control group: NGT irrespective of technique (e.g.,
conventional and looping).
We did not include studies with radiologically inserted gastros-
tomy (PRG), nasojejunal tubes, and jejunal tube percutaneous en-
doscopy gastrostomy (JET-PEG) in this review.
Types of outcome measures
Primary outcomes
• Intervention failures as defined by any event leading to
failure to introduce the tube, recurrent displacement and
treatment interruption (feeding interruption, blocking or leakage
of the tube, no adherence to treatment) (based on Norton 1996).
Secondary outcomes
• Nutritional status, as measured by any validated instrument
(such as upper-arm skin fold thickness, mid-arm circumference,
body weight, serum albumin level, haemoglobin (Ramel 2008)).
• Mortality.
• Adverse events (e.g., aspiration, haemorrhage, pneumonia,
wound infection, sinusitis, fistula).
• Time on enteral nutrition.
• Quality of life, as measured by any validated instrument
(such as EUROQoL, SF-36 (Dorman 1997)).
• Length of hospital stay.
• Costs and economic issues.
Search methods for identification of studies
Electronic searches
We performed a computerised literature search in, re-running
searches from the previous search date (August 2009). We carried
out updated searches in September 2011 and in January 2014.
• The Cochrane Central Register of Controlled Trials
(CENTRAL, 2013, Issue 12) and other databases in The
Cochrane Library (Appendix 1),
• Ovid MEDLINE(R) Daily Update January 31, 2014, Ovid
MEDLINE(R) In-Process & Other Non-Indexed Citations and
Ovid MEDLINE(R) 1946 to Present Appendix 2.
• EMBASE via OVID (Embase 1980 to 2014 Week 05)
Appendix 3.
• LILACS via BIREME (from inception to January 2014)
Appendix 4.
Search terms and their synonyms for clinical conditions of inter-
est to us (swallowing disturbance or dysphagia) and interventions
of interest (percutaneous endoscopic gastrostomy and nasogastric
tube feeding) are given in the appendices. They were adapted for
each of the databases. There was no language restriction in the
search. Search filters to identify randomised controlled trials in-
volving humans were used when appropriate.
Searching other resources
We compiled a reference list of relevant studies (irrespective of
study design) to identify trials with the potential for inclusion. We
contacted authors via email requesting the data from unpublished
trials. We also tried to identify ongoing trials on the Current Con-
trolled Trials Web site (www.currentcontrolledtrials.gov).
Data collection and analysis
Selection of studies
Two review authors (CG, RA) checked the titles and abstracts
found by the search strategy and other sources researched. When-
ever titles or abstracts seemed relevant to the review, we analysed
them by reading the full article. If theywere truly randomised con-
trolled trials that met the previously stated criteria, we included
them in the review. If there remained any doubt or disagreement,
all of the authors assessed the study in question.
Data extraction and management
Two review authors (CG, DRW) extracted data based on CON-
SORT (Moher 2001). For the update in 2014, CB with CG and
DRWextracted data fromnew included studies.We settled doubts
by consensus of the authors.
Assessment of risk of bias in included studies
Two review authors (CG, RBA, with CB) independently assessed
themethodological quality of included studies using the following
items (Higgins 2011).
• Random sequence generation (selection bias) . Biased
allocation to interventions due to inadequate generation of a
randomised sequence.
• Allocation concealment (selection bias). Biased allocation to
interventions due to inadequate concealment of allocations prior
to assignment.
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• Blinding (performance bias and detection bias).
Performance bias or detection bias due to knowledge of the
allocated interventions after assignment.
• Blinding of participants and personnel (performance bias).
Performance bias due to knowledge of the allocated
interventions by participants and personnel during the study.
• Blinding of outcome assessment (detection bias). Detection
bias due to knowledge of the allocated interventions by outcome
assessors.
• Incomplete outcome data (attrition bias). Attrition bias due
to amount, nature or handling of incomplete outcome data.
• Selective reporting (reporting bias). Reporting bias due to
selective outcome reporting.
• Other bias that is bias due to problems not covered
elsewhere in the table.
For the above biases, we classified studies according to their risk
of systematic error.
• High risk: when the appropriate method to avoid
systematic error was not met.
• Unclear risk: when the appropriate method to avoid
systematic error was not described or the information was not
acquired by contacting the authors of primary studies.
• Low risk: when the appropriate method to avoid systematic
error was met.
We did not use performance bias as a criterion to analyse the
risk of systematic error since this was not compatible with the
characteristics of the intervention.
Measures of treatment effect
For dichotomous and continuous variables, we calculated risk ratio
(RR), mean difference (MD), and 95% confidence intervals (CIs).
Whendata fromprimary studieswere not parametric (for example,
effects were reported as medians, quartiles) or without sufficient
statistical information (such as standard deviations, number of
patients), we inserted them into Table 1 if authors did not provide
the necessary information.
Unit of analysis issues
The unit of analysis was based on the individual patient (unit to
be randomised for interventions to be compared). We planned to
analyse events happening to a person more than once (for example
pneumonia, bronchoaspiration) by using risk ratio, which com-
pares the rate of events in the two groups (PEG and NGT) by
dividing one by the other. We planned to analyse cross-over study
designs separately from the parallel-group randomised controlled
trials.
Dealing with missing data
For continuous and dichotomous data, we carried out available
case analysis. In this update, for mean values of outcome data with
missing standard deviations, we calculated this from the differ-
ence between means (Cochrane Handbook for Systematic Reviews of
Interventions 7.7.3.3. Higgins 2011). We investigated the effects
of making these assumptions by performing sensitivity analyses
where appropriate.
Assessment of heterogeneity
We assessed statistical heterogeneity using the I² statistic. We as-
sumed a statistically significant heterogeneity between the esti-
mated effects of included studies with an I² > 50%.
Assessment of reporting biases
We had planned to assess publication bias by preparing a funnel
plot, and will do so in future versions of this review if a sufficient
number of studies is available. However, we are aware that asym-
metry in the funnel plot can be associated with reasons other than
that of publication bias (for example, by chance, real heterogeneity,
or clinical particulars inherent to each one of the included studies
such as patients at high risk for the outcome).
Data synthesis
Qualitative information
We synthesised qualitative information relative to methods, risk
of bias, description of participants, and outcomes measures in the
Characteristics of included studies table.
Quantitative information
For dichotomous variables, we calculated the risk ratio (RR). For
continuous variables, we calculated the mean difference (MD)
when studies reported their results through the same variables
measured with the same instruments (same units of measure).
When continuous data were measured with different instruments
(different and non-interchangeable units of measure), we planned
to pool them using the standardised mean difference (SMD). We
used 95% CIs for all statistical methods to pool data.
Irrespective of the nature of the data, we used a random-effects
statistical model as we were expecting substantial clinical and
methodological heterogeneity, which could generate substantial
statistical heterogeneity.
Subgroup analysis and investigation of heterogeneity
We planned to carry out subgroup analyses using different NGT
and PEG methods (for example pull, push, nasal loop, conven-
tional). We assumed that heterogeneity between studies in both
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the direction and magnitude of estimate effect had a suspected
causal relationship (the subgroup characteristic and the estimate
of effect), and we have considered these in the Discussion section.
Sensitivity analysis
Weplanned sensitivity analysis to examine the effects of intention-
to-treat (ITT) analysis and available data analysis for dichotomous
data. We planned to carry out ITT analysis by using imputation
based on the analysis of the total number of randomised partici-
pants, irrespective of how the original study authors analysed the
data. We assumed that all missing participants experienced the
event. The other factors were study quality, trials reported only in
abstracts, and testing for fixed-effect and random-effects statistical
models.
R E S U L T S
Description of studies
See Characteristics of included studies and Characteristics of
excluded studies for more information.
Results of the search
For details of the process of studies selection, see Figure 1.
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Figure 1. Study flow diagram.
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The first literature search (August 2009 to September 2011)
yielded 474 hits. From this, 18 papers were retrieved for full text
review. Three papers were excluded due to inappropriate study de-
sign and intervention. In January 2014, an update search yielded
663 additional records and two additional studies were identified
for inclusion in the review.
Included studies
The 11 randomised controlled studies selected were published in
English. In many cases the data we required were not available
in the published report of the study and we obtained further in-
formation from the study investigators (e.g. Bath 2009; Corry
2008b), whichwere used to estimate the effects of the interventions
for clinically relevant outcomes (i.e., treatment failure, mortality,
pneumonia, adverse events, and length of hospital stay). Yata 2001
was only available in abstract form, which hampered the gleaning
of all the relevant data, and the corresponding author could not
be contacted. Data from another study (Bath 1997) came from a
systematic review by the same author, and doubts were resolved
via email with the corresponding author. Elbadawy 2014 was an
unpublished study and we obtained further information by cor-
respondence with the study investigator.
Participants and study design
We sought to compare percutaneous endoscopic gastrostomy
(PEG) (n = 373 participants) with nasogastric tube (NGT) (n =
362 participants) placement for enteral feeding in adults (n = 735
total randomised participants).
The sample in Baeten 1992 included patients with different dis-
eases, including neoplasia of the ear, nose, and throat and neuro-
logic and post-operative diseases. The mean age of these patients
was 72 years (range: 62 to 82 years). Park 1992 included only
patients with dysphagia secondary to neurologic diseases in their
sample. The mean age of these patients in the NGT group was
65 years, whereas the mean age of those in the PEG group was
56 years. Norton 1996 and Bath 1997 included in their sample
patients with dysphagia after acute stroke with a mean age of 77
years. Yata 2001 studied patients with dysphagia in several dis-
eases, such as dementia, Parkinson’s disease, and cerebrovascular
disease. These patients had a mean age of 75.1 years (range: 50 to
96 years) in the PEG group and 76.5 years (range: 38 to 93 years)
in theNGT group. Dennis 2005 included in their sample patients
who presented with dysphagia after acute stroke. Their mean age
was 76 years (SD = 10 years). Douzinas 2006 assessed patients
with different diseases, some of whom presented with recurrent or
persistent ventilator-associated pneumonia. These patients had a
median age of 53 years (range: 20 to 82 years) in the PEG group
and 58 years (range: 25 to 85 years) in the NGT group. Hamidon
2006 investigated patients with dysphagia after acute stroke with
a median age of 65 years (range: 48 to 79 years) in the PEG group
and 72 years (range: 54 to 77 years) in the NGT group. Finally,
Corry 2008 included in their sample patients with cancer of the
head andneckwith amedian age of 60 years (range: 46 to 80 years).
In Sadasivan 2012, participants had advanced stage two or three
squamous cell carcinoma of the head and neck and were scheduled
either for radical surgery with adjuvant radiotherapy (RT), chemo-
RT, or for concurrent chemo and radiation therapy were included
in the study. The age of participants in the study was not reported
and we were unable to obtain further data. Elbadawy 2014, in-
cluded participants with close traumatic severe brain injury in a
study to determine whether PEG or NGT resulted in lower rates
of ventilator-assisted pneumonia. The mean age of participants in
the study was not reported and we were unable to obtain further
data.
Interventions and comparisons
The interventions were PEG, inserted by any method, versus
NGT. Further details can be found in the Characteristics of
included studies tables.
In Elbadawy 2014, a three-arm study, NGT plus intubation was
compared with PEG plus intubation and PEG plus tracheostomy.
For the purposes of this review, we combined the two PEG groups
and compared these results with the NGT group.
Outcomes
Follow-up times varied across the 11 studies analysed. Baeten
1992, Douzinas 2006, Park 1992, and Hamidon 2006 studied
patients for no more than four weeks. On the contrary, the follow-
up times of Bath 1997, Dennis 2005, Norton 1996, Yata 2001,
and Corry 2008 ranged from three to six months. Elbadawy 2014
and Sadasivan 2012 followed up participants at one week, six
weeks and six months.
The included studies reported our review outcomes as follows:
Our primary outcome, intervention failure, was reported in eight
studies (Baeten 1992; Bath 1997; Corry 2008; Hamidon 2006;
Norton 1996; Park 1992; Sadasivan 2012; Yata 2001). Elbadawy
2014 reported the number of adverse events in each group; we re-
quested further information, but the study investigators were not
able to provide the number of patients with the primary review
outcome of intervention failures (e.g., feeding interruption, block-
ing or leakage of the tube, no adherence to treatment). Participant
non-adherence to treatment was reported in Sadasivan 2012,
Mortality was reported in nine studies (Baeten 1992; Bath 1997;
Corry 2008; Dennis 2005; Douzinas 2006; Elbadawy 2014;
Hamidon 2006; Norton 1996; Park 1992).
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Adverse effects were reported in seven studies (Baeten 1992; Corry
2008; Dennis 2005; Douzinas 2006; Elbadawy 2014; Norton
1996; Sadasivan 2012). Pneumonia, the result of aspirating food
into the airway, was reported in seven studies (Baeten 1992; Corry
2008; Dennis 2005; Douzinas 2006; Elbadawy 2014; Norton
1996; Yata 2001). Reflux oesophagitis was reported in Yata 2001.
Two studies additionally reported measures related to the nu-
tritional status of the participants: weight gain (Norton
1996; Sadasivan 2012), mid-arm circumference (Norton 1996;
Sadasivan 2012), serum albumin levels (Norton 1996), and hae-
moglobin levels (Sadasivan 2012).
The length of hospital stay was reported in two studies (Dennis
2005; Elbadawy 2014); and the time of entry nutrition in days
was reported in Baeten 1992 and Park 1992.
Other outcome measures included quality-of-life measures using
the EORTC QLQ-H&N35 scale in Corry 2008 and Sadasivan
2012. Scores of patient satisfaction and inconvenience of main-
taining PEG or NGT by nursing staff were reported in Baeten
1992; it is unclear if these were validated scales. Participant func-
tional ability (modified Rankin scale (MRS)), an indicator of qual-
ity of life, was reported in Dennis 2005.
The mean survival time in months was reported in Yata 2001.
Excluded studies
The three excluded studies did notmeet the aforementioned inclu-
sion criteria. McClave 2005 conducted a randomised controlled
trial without interventions of interest for this review;Mekhail 2001
and Schulz 2009 performed retrospective studies. McClave 2008
was excluded following contact with the corresponding author to
clarify the randomisation process employed.
Risk of bias in included studies
See Figure 2 and Figure 3.
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
The methods employed for allocation by Bath 1997; Corry 2008;
Dennis 2005; Elbadawy 2014; Hamidon 2006; Park 1992 were
suitable for this procedure; therefore, they were deemed low risk
for systemic errors of a methodological nature. The remaining
studies in this review (i.e., Baeten 1992; Douzinas 2006; Norton
1996; Sadasivan 2012; Yata 2001) were considered to be unclear
for risk of bias because the methods used for allocation were not
reported.
The methods used for allocation by Dennis 2005; Baeten 1992;
Park 1992; and Norton 1996 were sufficiently sound to ensure
concealment of the allocation process. Consequently, they were
deemed low risk for systematic errors of a methodological nature.
On the contrary, the studies by Bath 1997; Corry 2008; Douzinas
2006; Hamidon 2006; Sadasivan 2012; Yata 2001 were consid-
ered to be unclear for risk of bias. Although the authors described
random allocation, they did not report the methods used for allo-
cation concealment. No attempt was made to conceal allocation
in Elbadawy 2014.
Overall, no unusually large differences were noted in the demo-
graphic characteristics of patients from each group on study entry,
except in Sadasivan 2012, where there were more participants in
the PEG group who had radical surgery and adjuvant radio or
chemotherapy, and more participants in the NGT group had con-
current chemo or radio therapy. Participants in the NGT group
weighed more at the start of the trial.
Blinding
The characteristics of the interventions compared in this sys-
tematic review prevented the patients and physicians from be-
ing blinded to the interventions. Eight studies made no mention
of blinding data assessors (Bath 1997; Douzinas 2006; Elbadawy
2014; Hamidon 2006; Norton 1996; Park 1992; Sadasivan 2012;
Yata 2001). Three studies were considered as of high risk of detec-
tion bias, because their authors explicitly described either the ab-
sence of (Baeten 1992; Corry 2008), or flawedmethod of blinding
data assessors (Dennis 2005).
Incomplete outcome data
Nine studies clearly reported both missing data and the flow of
the patients during the study. As a result, they were considered low
risk for systematic errors in follow-up losses. However, Yata 2001
and Sadasivan 2012 did not report losses or patient flow in their
work; therefore, the study was considered to be unclear for risk of
bias for this domain.
In Park 1992, 18 of the 19 patients in the NGT group presented
intervention failure. The researchers did not follow these patients
for the full 28 days. In contrast, all 19 patients from the PEG
group completed the recommended follow-up period. Despite the
significant number of failures in the NGT group, this clinical
trial was considered low risk for systematic error for dichotomous
variables because the authors clearly described the flow of patients
from randomisation through to the study endpoint.
Selective reporting
All of the studies were associated with a low risk of bias, given that
relevant outcomes were reported in all cases.
Other potential sources of bias
The following studies were rated as having a high risk of bias:
Baeten 1992 (follow-up not previously established), Bath 1997
and Yata 2001 (unpublished studies), Park 1992 (dropout rate
of 95% (19/20) in the NGT group due to treatment failure and
death).
Effects of interventions
See: Summary of findings for the main comparison
Percutaneous endoscopic gastrostomy compared with nasogastric
tube feeding for adults with swallowing disturbances
Comparison 1: percutaneous endoscopic gastrostomy
versus nasogastric tube
Primary outcomes
Intervention failure
The outcome of intervention failure (e.g., feeding interruption,
blocking or leakage of the tube, no adherence to treatment) was re-
ported in eight studies comprising 408 participants (Baeten 1992;
Bath 1997; Corry 2008; Hamidon 2006; Norton 1996; Park
1992; Sadasivan 2012; Yata 2001). We were unable to obtain data
on overall intervention failure rates in each group from Elbadawy
2014.
Failure occurred in 9.22% (19 out of 206 participants) in the
PEG group and 39.11% (79 out of 202 participants) in the NGT
group. A meta-analysis of these eight studies using the random-
effects model favoured the PEG group, that is, fewer participants
in the PEG group experienced an intervention failure (risk ratio
(RR) 0.18, 95% confidence interval (CI) 0.05 to 0.59, P = 0.005;
Analysis 1.1) (Mantel-Haenszel’s statistical method). We found
significant statistical heterogeneity in this analysis; I2 = 73%.
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Non-adherence to treatment
Non-adherence to treatment at six weeks was reported in only
one study, Sadasivan 2012 and was not statistically significantly
different in an analysis of 94 participants (RR 0.07, 95% CI 0.00
to 1.17). Intention-to-treat (ITT) analyses of non-adherence at six
weeks (RR 0.02, 95% CI 0.00 to 0.36) and at six months (RR
0.01, 95%CI 0.00 to 0.16) however, were statistically significantly
different and favoured the PEG group Analysis 1.2.
Subgroup analyses
We further subgrouped the studies by endoscopic gastrostomy
technique into pull (n = 90), push (n = 33), and not reported (n =
285) inAnalysis 1.3.Weobserved a significant difference favouring
PEG in the pull subgroup (RR 0.07, 95% CI 0.01 to 0.35, three
studies, P = 0.001). Thepush subgroup contained only one clinical
trial and the result favoured PEG (RR 0.05, 95% CI 0.00 to
0.74, P = 0.03) techniques. We found no statistically significant
difference in cases where technique was not reported (RR 0.43,
95% CI 0.13 to 1.44). Statistically significant heterogeneity was
found in the unreported technique subgroup (I² statistic = 73%),
and the statistical significance of this result was unchanged in ITT
analyses (RR 0.37, 95% CI 0.09 to 1.45) Analysis 1.5.1.
Wemade a post-hoc decision to investigate the possible reasons for
this heterogeneity in Analysis 1.4 using subgroup analysis. There-
fore we subgrouped the studies by participant condition (Analysis
1.4). For participants with cerebrovascular events or neurological
baseline diseases (n = 109), the result favoured the PEG group (RR
0.08, 95% CI 0.02 to 0.33, P = 0.0005). There was no statistical
heterogeneity in this analysis. For participants with mixed base-
line diseases (n = 299), the intervention favoured neither PEG nor
NGT(RR 0.32, 95% CI 0.08 to 1.32), and statistical heterogene-
ity was high (I2 = 79%), The statistical non-significance of this
result, was unchanged in ITT analyses (RR 0.29, 95% CI 0.06 to
1.33; Analysis 1.5.2).
Secondary outcomes
Mortality
The outcome of mortality was examined in nine studies (Baeten
1992; Bath 1997; Corry 2008; Dennis 2005; Douzinas 2006;
Elbadawy 2014; Hamidon 2006; Norton 1996; Park 1992) (644
participants) and was assessed independently of study follow-up
time. The results showed 35.76% (118 out of 330 participants) in
the PEG group and 36.62% (115 out of 314 participants) in the
NGT group (RR 0.86, 95% CI 0.58 to 1.28) (Mantel-Haenszels
statistical method). The result of the meta-analysis for mortality
revealed no statistically significant difference between comparison
groups. Finally, we observed statistical heterogeneity between in-
cluded studies: I² statistic = 47%. Because of the radiologically
placed gastrostomy technique used in a small number of partici-
pants in Dennis 2005, we carried out a sensitivity analysis to test
the differences in the estimate effects by including and excluding
this study. The sensitivity analysis shows that the inclusion of the
FOOD study (Dennis 2005) did not change the statistical signifi-
cance of the result for mortality (RR 0.81 (95%CI 0.47 to 1.41, P
= 0.84; Analysis 1.6) without Dennis 2005 (analysis not shown).
One study (n = 82) reported the mean survival time in months
(Yata 2001) (MD 4.3, 95% CI 3.28 to 5.32; Analysis 1.7). The
result favoured the PEG group, that is participants in the PEG
group survived longer, for a mean of 11.4 months compared with
7.1 months in the NGT group.
Complications and adverse effects
Complications and adverse effects (e.g., aspiration, haemorrhage,
wound infection, sinusitis, fistula) were examined in six studies
(Baeten 1992; Corry 2008;Dennis 2005; Douzinas 2006; Norton
1996; Sadasivan 2012) (597 participants) and was assessed inde-
pendently of study follow-up time or severity of adverse effect.
Although some of adverse events were characteristic of only one
intervention, we analysed them together for the purposes of this
review. The results showed 35.67% (107 out of 300 participants)
in the PEG group and 45.79% (136 out of 297 participants) in the
NGT group had adverse effects (RR 0.83, 95% CI 0.51 to 1.34;
Analysis 1.8) (Mantel-Haenszel’s statistical method). The result of
the meta-analysis for adverse effects revealed no statistically signif-
icant difference between the groups. We observed high statistical
heterogeneity in the comparison: I² statistic = 87%. An ITT anal-
ysis of these data did not change the statistical significance of the
result (RR 0.81, 95% CI 0.48 to 1.35; Analysis 1.9)
In Elbadawy 2014, which was a study of critically ill participants
who had experienced head injury, adverse events associated with
PEG tracheostomy and nasogastric tube were reported. Adverse
events were reported as number of events, rather than number of
participants experiencing adverse events (that is, participants may
have experienced more than one type of adverse event). In this
study, the adverse events in the PEG group were infection in the
gastrostomy tube in 19 participants, leakage around the gastros-
tomy tube in 21 participants, dislodgement of the gastrostomy
tube in 19 and obstruction of the PEG tube in two participants.
Fistulas, perforations and ’buried pumper’ syndrome (where the
PEG tube migrates) were not seen. In the NGT group, paranasal
sinusitis from the nasogastric tube was found in 12 participants
(60%) (Table 2).
Aspriration (pneumonia)
The outcome of pneumonia (as a result of aspiration) was exam-
ined in seven studies (Baeten 1992; Corry 2008; Dennis 2005;
Douzinas 2006; Elbadawy 2014; Norton 1996; Yata 2001) (645
participants) and was assessed independently of study follow-up
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time. The results showed 31.93% (106 out of 332 participants)
pneumonia in the PEG group and 41.54% (130 out of 313 par-
ticipants) in the NGT group (RR 0.70, 95% CI 0.46 to 1.06;
Analysis 1.10). However, the result of the meta-analysis for the
pneumonia outcome did not favour PEG.We observed high levels
of statistical heterogeneity between studies: I² statistic = 81%.
Reflux oesophagitis
Douzinas 2006 reported median change in gastro-oesophageal re-
flux at endpoint (day seven) as percentage of the time when the
oesophageal pH was less than 4 in a given 24-hour period of time.
The percentage was statistically significant, that is, less severe re-
flux was seen in the PEG group.
Yata 2001 reported reflux oesophagitis. In this single study analysis
of 82 patients in total, there was a statistically significant result
that favoured the PEG group (RR 0.45, 95% CI 0.22 to 0.92;
Analysis 1.11).
Nutritional status
We analysed data for nutritional status, as measured by any vali-
dated instrument (e.g. as upper-arm skin fold thickness, mid-arm
circumference, body weight, serum albumin level, haemoglobin)
Weight
In a single study analysis of weight (kg) at the study endpoint
(Norton 1996) (mean difference (MD) 3.20, 95% CI -5.95 to
12.35; Analysis 1.12) The outcome favoured neither NGT or
PEG. Three studies contributed to an analysis of weight change
from baseline (n = 148, Corry 2008; Norton 1996; Sadasivan
2012) (MD3.11, 95%CI -0.52 to 6.75; Analysis 1.13), that is, the
outcome favoured neither NGT or PEG. In this analysis statistical
heterogeneity was high I2 = 93%.
Mid-arm circumference
Norton 1996 reported mid-arm circumference in centimetres at
the end point of the study and the change from baseline. The pub-
lished report of Corry 2008 provided upper-arm circumference
data for the NGT and PEG group as the median 300 mm (range
240 to 352) verus PEG 302.5, P= 0.69 (range 270 to 370) (mean
283 mm versus 295 mm respectively, P=0.25, not statistically sig-
nificant, no standard deviations (SDs) reported Table 1). We cal-
culated the missing SD values for the data from Corry 2008 and
the result for a meta-analysis of both studies (n = 54) for arm cir-
cumference favoured neither intervention or control (MD 1.58,
95% CI -0.11 to 3.27; Analysis 1.14). No statistical heterogene-
ity was observed in this analysis I2 = 0%. This overall result was
unchanged in a sensitivity analysis (MD 2.50, 95% CI -0.64 to
5.64; Analysis 1.14.2)
The change in mid-arm circumference from baseline was mea-
sured in Norton 1996 and Sadasivan 2012. In this analysis of 115
participants, the results were statistically significant in favour of
PEG (MD 1.16, 95% CI 1.01 to 1.31; Analysis 1.15).
The included studies also reported anthropometric outcome data
as median values which we could not include in our meta-analyses
(Table 1).Median triceps skin fold thickness was reported inCorry
2008 and Hamidon 2006 and these were not significantly differ-
ent in either study, however in Corry 2008, the study reports states
that the NGT patients had significantly lower triceps skin fold
thickness (mean 9.5 versus 13.5 mm; P = 0.03 than the PEG pa-
tients at six weeks post-treatment). Median biceps skin fold (mm)
and median arm circumference was reported in Hamidon 2006
(Table 1) and the differences between groups were not statistically
significantly different in either case.
Serum albumin
Mean serum albumin levels (g/dL) were reported in Yata 2001 and
Norton 1996.
Yata 2001 was a short conference report and did not include SD
values but reported that the serum albumin levels at three and
six months were significantly different in the study report of Yata
2001 favouring PEG (P = <0.01) (Table 1). We calculated SD for
this study using the difference between means and in an analysis
of albumin levels of two studies of 107 participants, the result
was statistically significant favouring the PEG group (MD 6.03,
95% CI 2.31 to 9.74; P = 0.001). Statistical heterogeneity was
high I2 = 75%. In a sensitivity analysis excluding Yata 2001, the
result remained statistically significant, that is, using data only
from Norton 1996, an analysis of albumin levels at endpoint in
25 participants indicated a statistically significant result in favour
of PEG (MD 7.80, 95% CI 5.52 to 10.08; Analysis 1.16).
Sadasivan 2012 reported change in albumin levels from baseline
and again this result was statistically significant in an analysis of
94 participants favouring PEG (MD 0.12, 95% CI 0.11 to 0.14;
Analysis 1.17).
The median serum albumin endpoint values were lower in the
NGT group in Hamidon 2006 (P = 0.054) (Table 1).
Hamidon 2006 also reported nutritional status outcome data as
median values which we could not include in our meta-analyses
(Table 1). Median serum albumin (g/L) was 39.5 (R 36 to 44) in
the PEG groups versus 36.0 (R 31 to 45) in the NGT group. The
P value was 0.045, which was statistically significantly different .
Haemoglobin
Haemoglobin levels were reported as a change from baseline in
Sadasivan 2012, In this single study analysis of 94 participants, the
results favoured PEG and was statistically significant (MD 0.59,
95% CI 0.49 to 0.69; Analysis 1.18).
Yata 2001 reported that mean haemoglobin levels (g/L) were 11.7
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in theNG group and in the PEG group were 11.9 at three months,
and 11.1 versus 12.4 at six months (Table 1).
Time of enteral nutrition
Two studies (n = 119) reported the duration of enteral feeding
in days (Baeten 1992; Park 1992) (MD 14.48, 95% CI -2.74 to
31.71; Analysis 1.21), this favoured neither NGT nor PGT and
there were high levels of statistical heterogeneity present in this
analysis (I² = 94%). These results should be interpreted cautiously
as the assumption of normality for these outcomes may not be
met.
Length of hospital stay
Two studies (n= 381) reported the length of hospital stay in days
(Dennis 2005; Elbadawy 2014) (MD -12.67, 95% CI -40.18 to
14.84; Analysis 1.24), this favoured neither NGT nor PGT. There
were high levels of statistical heterogeneity present in this analysis
(I² = 93%). These results should be interpreted cautiously as the
assumption of normality for these outcomes may not be met.
Quality of life
Patient satisfaction
Patient satisfaction was reported in Baeten 1992 (a five-point
graded scale graded from 1 = very satisfied to 5 = very dissatisfied).
In an analysis of 43 participants, the result favoured neither PEG
nor NGT (MD -0.56, 95% CI -1.32 to 0.20) (Analysis 1.19).
The inconvenience score (that is, inconvenience of maintaining
the intervention to nursing staff in a scale with five categories)
was also a statistically non-significantly different in an analysis of
68 patients in Baeten 1992 (MD -0.58, 95% CI -1.18 to 0.02;
Analysis 1.20).
Quality-of-life was measured in two studies (Corry 2008;
Sadasivan 2012) and included in a meta-analysis (Analysis 1.22),
Using the EORTC QLQ-H & N 35 Scale, and the number of
participants who scored three or four (in this scale a high score is a
worse outcome), the outcomes of pain, in an analysis of 133 par-
ticipants, (RR 0.33, 95% CI 0.00 to 471.74) and ease of learning
to use (RR 0.18, 95% CI 0.00 to 149.53), there was no statisti-
cally significant difference between the PEG and the NGT group.
In analyses of 133 participants each for the outcomes of inconve-
nience (RR 0.03, 95% CI 0.00 to 0.29; P=0.002) and discomfort
(RR 0.03, 95% CI 0.00 to 0.29; P = 0.002), altered body image
(RR 0.01, 95% CI 0.00 to 0.18; P = 0.001), and social activities
(RR 0.01, 95% CI 0.00 to 0.18; n= 100, P = 0.001), the inter-
vention favoured PEG, that is, fewer participants found the inter-
vention of PEG to be inconvenient, uncomfortable or interfered
with family life or social activities, and this was a statistically sig-
nificantly different between the groups. There was statistical het-
erogeneity present in the analysis of pain (I² = 95%) and ease of
learning to use (I² = 94%), and low levels of statistical heterogene-
ity in the analyses of inconvenience and discomfort (I² = 21%).
The outcome of family life could not be entered into a meta-
analysis as Corry 2008 did not report this subscale. Using data
from Sadasivan 2012 only, this outcome favoured the PEG group
and this was a statistically significantly different (RR 0.01, 95%
CI 0.00 to 0.18; n=100, P = 0.001).
Dennis 2005 reported the mean difference between comparison
groups at endpoint derived from the EuroQol (reported as 0.035
95% CI -0.024 to 0.093). We could not include these data in our
meta-analyses, but the report of the study states that the results
were not statistically significantly different.
Functional ability
A decline in functional ability while under treatment may be re-
lated to overall quality of life. Functional ability is the ability to
perform basic activities of daily life without support, an impor-
tant aspect of overall independence and quality of life. Just one
study reported functional ability by using a modified Rankin Scale
(MRS) (Dennis 2005). There was no statistically significant dif-
ference between comparison groups (Analysis 1.23) for the fol-
lowing ranges of Modified Rankin Scales (MRS): MRS 0 to 3 (RR
0.59, 95% CI 0.34 to 1.01, P = 0.06) and MRS 4 to 5 (RR 1.20,
95% CI 0.90 to 1.61, P = 0.21) and for the outcome composed
by MRS scales from 4 to 5 or death as showed by the RR of 1.10,
95% CI 1.00 to 1.20, P = 0.05).
Costs and economic issues
Only one study provided information about costs and we did not
include these data in any analyses. Corry 2008 stated that the “cost
of each feeding tube is $26 for a NGT and $110 for a PEG tube”
and “The insertion costs are significantly different as the NGT
are inserted by nursing staff in outpatients and the PEG tubes are
inserted by surgeons in theatre. The cost for insertion of a NGT is
$50 (includes nursing time and cost of chest X-ray), whereas the
cost of insertion of a PEG tube is $626”.
D I S C U S S I O N
Summary of main results
This systematic review of 11 included studies comprising 735 ran-
domised participants in total (373 receiving percutaneous endo-
scopic gastrostomy (PEG) and 362 nasogastric tube (NGT)), pro-
duced 16 meta-analyses in total, for the primary outcome of in-
tervention failure (subgrouped by gastrostomy technique and by
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baseline disease) and for the secondary outcomes of mortality, ad-
verse effects in total and also pneumonia as a result of aspiration,
nutritional status including weight change from baseline, mid-
arm circumference at endpoint and change from baseline, time of
enteral nutrition in days, length of stay in days, and quality of life
measured by the EuroQol scale.
In our meta-analyses, overall, the estimated effects for the primary
outcome of intervention failure showed a statistically significant
lower risk in the PEG group compared with the NGT group, and
this was confirmed in subgroup analyses of intervention failure
for both the ’push’ and ’pull’ gastrostomy techniques (subgroup
analysis of those studies which did not report the gastrostomy
technique showed no statistically significant difference between
PEG or NGT). However, we cannot infer from the effect sizes
that one technique (push or pull) is superior to the other as we
did not carry out comparisons (indirect analysis) of the different
techniques using data from separate studies.
We carried out additional intention-to-treat (ITT) analyses for the
outcome of intervention failure specifically for the four studies
with participants with mixed baseline diseases, and for interven-
tion failure in the four studies where the gastrostomy technique
was not reported, and we found no statistically significant differ-
ences between the PEG and NGT groups.
No direct causal relationship with the procedures was established
for the secondary outcome ofmortality i.e. therewas no statistically
significant difference between PEG or NGT for this outcomes.
Only Dennis 2005 and Baeten 1992 reported a relationship be-
tween procedure-related mortality and global mortality, ranging
from 0% to 10%. These low rates support the notion that the
use of these methods may have no significant influence on risk of
death.
Meta-anaysis of adverse effects irrespective of follow-up time
showed no statistically significant differences between the groups,
and an ITT analysis of five studies for this outcome showed no
statistically significant differences between the PEG and NGT
groups. Fewer participants in the PEG group experienced pneu-
monia, an adverse event precipitated by aspiration of stomach con-
tents or oro-pharyngeal secretions into the airway, but this differ-
ence was not statistically significant.
The meta-analyses of the secondary outcome of nutritional status
i.e. weight change from baseline showed no statistically significant
difference between the groups; endpoint mid-arm circumference
was not statistically significantly different between the groups, al-
though the outcome of mid-arm circumference in centimetres
(change from baseline) was statistically significant in favour of
PEG.
The meta-analysis of quality-of-life measures (a secondary out-
come) was statistically significant favouring PEG (that is, more
patients in the NGT group reported worse outcomes) for the out-
comes of inconvenience, discomfort, altered or bad body image,
social activities and in a single study analysis, interference with
family life.
We also present analyses of data from single studies for the primary
outcome of intervention failure that is non-adherence to treat-
ment, and the secondary outcomes of adverse effects (specifically
reflux oesophagitis), nutritional status including weight at end-
point, serum albumin levels and change from baseline, changes in
haemoglobin levels g/dL from baseline, and measures of quality of
life including scores of patient satisfaction and of inconvenience
in maintaining the PEG or NGT by nurses, participant functional
ability, and impact on family life measured by the EORTCQLQ-
H&N35 (in one study).The single study analyses of the primary
outcome non-adherence to treatment was statistically significant
in favour of the PEG group at the six-week and six-month follow-
up point in Sadasivan 2012 and notably all the dropouts from
treatment were from the NGT group in that study (at six months
there were no patients in the NGT group due to resumption of
oral feeds (n = 10) or conversion to a PEG tube (n = 34).
For the secondary outcome of adverse effects, fewer patients in the
Yata 2001 study reported reflux oesophagitis in the PEG group
and this was statistically significant favouring PEG. For the sec-
ondary outcome of nutritional status, the mean participant body
weight in kilograms at the endpoint, showed no statistically signif-
icant difference favouring PEG or NGT. Serum albumin levels at
endpoint were statistically significant in Norton 1996, favouring
the PEG group and also the serum albumin change from baseline
were statistically significant favouring PEG in Sadasivan 2012.
Haemoglobin levels expressed as a change from baseline also were
higher in the PEG group and this was a statistically significant in
the only study that reported this outcome (Sadasivan 2012).
Outcomes relating to quality of life, including the scores of patient
satisfaction and inconvenience in maintaining the intervention by
nurses as reported in Baeten 1992, were not statistically significant
in favour of either PEG or NGT. Functional ability reported in
Dennis 2005 favoured neither PEG nor NGT.
Analyses of time on enteral nutrition and length of hospital stay
favoured neither PEG nor NGT. However, these analyses of time
are very unlikely to follow a normal distribution, so the analyses of
mean differences are not necessarily accurate.These results should
be interpreted cautiously as the assumption of normality for these
outcomes may not be met.
These conclusions were not changed by the 2014 update of the
review.
Overall completeness and applicability of
evidence
Based on the findings of this review, outcomes in participants who
received nutritional support via a PEG may be more favourable
that in those who have a NGT, especially for the outcome of
intervention failure, based on an examination of 408 participants
who had heterogeneous clinical and demographic characteristics.
Participants receiving PEG may be more likely to adhere to treat-
ment at six weeks and six months. However, we found no evidence
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of a difference in mortality or adverse events (aspiration pneumo-
nia) between the comparison groups. This non significant result
does not imply no difference and we suggest that the review may
not have had sufficient power to look at these less common events.
Participants receiving PEGmay experience less reflux oesophagitis
(an adverse event). There is limited evidence, derived from single
study results and small meta-analyses that PEG results in better
outcomes in terms participants’ nutritional status (mid-arm cir-
cumference, haemoglobin levels and serum albumin), and report
better quality of life.
We found clinical heterogeneity between the studies and noted
statistical heterogeneity in some of our analyses. For example, for
our analyses of intervention failure, our primary outcome, we ob-
served high levels of statistical heterogeneity resulting from the in-
clusion of the Baeten 1992 and Yata 2001 trials. One explanation
for this may be the clinical heterogeneity between the trials, with
the participants having different baseline diseases.Wemade a post-
hoc decision to investigate the possible reasons for heterogeneity
in the intervention failure meta-analysis as we assumed that the
source of this statistical heterogeneity would be related to clini-
cal heterogeneity. We hypothesised that baseline disease may have
contributed to clinical heterogeneity and we categorised the stud-
ies by baseline disease, i.e. cerebrovascular event or neurological
disorder versus mixed baseline disease (i.e. participants who may
have had severe co-morbidities including cancer) and found that
for the outcome of intervention failures in participants with cere-
brovascular or neurological disease only, the results favoured PEG
(i.e. fewer participants in the PEG group experienced any of the
adverse events evaluated in the studies), but there was no difference
between the groups for the mixed baseline disease subgroups and
these studies included Baeten 1992 and Yata 2001. However, our
hypothesis and the results of this analysis only point to one possi-
ble cause of heterogeneity, and this should be adequately tested in
future studies. One further source of clinical heterogeneity in the
remaining analyses could be because of the different techniques
used to insert the PEG.
Many of the studies reported continuous outcome data in a for-
mat that could not be incorporated in to our meta-analyses for
example, median values. This limited the number of analyses that
we could perform and we reported these data narratively in the
review. Information reported in this way should be regarded as
providing additional information only and the analyses we per-
formed including meta-analysis, forest plots, tests for statistical
heterogeneity provide more precise estimates of effects.
Quality of the evidence
The findings of the present review of the literature should be in-
terpreted with caution, given that almost half of the authors failed
to report the method used to sequence and conceal the allocation
(Figure 2; Figure 3). This is one of the main causes of error in
randomised systematic studies. In addition, other potential risks
of bias stemmed from the absence of prior planning of follow-
up time, as well as the unpublished or high rates of losses during
follow-up. However, almost all of the authors attempted to pre-
vent attrition by making the flow of patients clear and through
selective reporting bias by selecting clinically relevant outcomes.
There are also challenges relating to the study design in terms of
the numbers available for randomisation, following up such se-
riously ill patients and the high cost of the procedures in ques-
tion. These factors may explain why the majority of studies in-
volve small samples. It should be noted that all of the studies were
judged at high risk of performance bias because it is not possible
to blind participants and personnel in studies of this nature. In all
cases of uncertainly we attempted to obtain further information
or disaggregated data from the trial investigator, but where this
was not available it was because the investigator no longer had
access to historical trial data, or was unable to provide additional
information. This systematic review of the literature is valuable
in analysing 11 studies, thereby increasing the sample size to 735
participants. Nevertheless, further randomised clinical trials that
adopt a rigorous method are warranted.
We rated the overall quality of the evidence as moderate or low for
the key outcomes of treatment failure, mortality, pneumonia and
adverse events (Summary of findings for the main comparison),
resulting in lower confidence in the estimate of effect for those
outcomes and further research is likely to have an important im-
pact in our confidence in the estimate of effect and may even
change the estimate. Where we downgraded the evidence, it was
because there was risk of bias in the trial, out of eight estimates of
potential bias (random sequence generation; allocation conceal-
ment; incomplete outcome data; selective reporting; blinding of
participants and personnel; blinding of outcome assessment, and
other bias) only six studies obtained scores of four or more. The
included studies involved relatively few participants and wide con-
fidence intervals (imprecision), although it is accepted that large
scale studies of this type would be very difficult to perform. The
results of many meta-analyses had high levels of statistical hetero-
geneity (inconsistency).
Potential biases in the review process
In view of the sensitive search strategy involving electronic corre-
spondence with the eminent authors in this area of research, we
believe that it is highly unlikely that other studies meeting the in-
clusion criteria of this systematic review were overlooked, however
this remains a possibility and could be regarded as a limitation of
this review.
While we included adverse effects reported in the studies included
in this the review, wemay not have detected reports of all of serious
and/or rare adverse events associated with PEG or NGT, and in
common with many systematic review and meta-analyses, this is
a could be limitation of this review.
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As outlined, all efforts weremade to ensure that relevant qualitative
or quantitative data were included in this review.
Agreements and disagreements with other
studies or reviews
In one of themajor controlled randomised trials performed to date
(Dennis 2005), the authors suggested that NGT should be the
method of choice in the first two to three weeks of enteral feeding,
probably in light of the increased absolute risk of death associated
with the use of PEG (RR1.02, P =0.86) and the absolute risk of the
outcome composed by MRS scale (modified Rankin scale) from
four to five or death (RR 1.10, P = 0.05). However, combining
the results of 11 different studies with 400 patients, it seems that
the PEG option is associated with a lower risk of intervention
failure. Given the importance of this finding, selecting PEGmight
reduce the difference in cost between the two procedures. The
findings of all of the other studies included in this analysis seem to
support the use of PEG. Guidelines suggest that PEG is a highly
effective and safe procedure when modern equipment is used,
established standards are followed (Löser 2005).However, a careful
patient selection and professional proficiency are fundamental for
better outcomes (Blumenstein 2014; Skitt 2011). In a narrative
review, Plonk 2005 suggested that the use of PEG should only be
considered in amyotrophic lateral sclerosis, intestinal blockage by
malignant tumour with incoercible vomiting, persistent dysphagia
after acute stroke, and early head and neck cancer. However, the
results of a systematic review that included studies with different
designs suggests that PEG and NGT have the same effectiveness
and safety for patients with head and neck cancer, even considering
relevant outcomes, such as mortality and nutritional status (Wang
2014). Although no study included in our systematic review made
available information about the use of nasal looping technique,
there is some evidence that such NGT technique has potential to
be preferable over PEG (Anderson 2004).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Based on the findings of this meta-analysis, the results favoured
PEG rather than NGT for intervention failure, but not for mor-
tality and pneumonia rates, and other adverse events. There may
be some advantage in terms of nutritional status in using PEG over
NGT, and patients may report better quality of life when using a
PEG tube.
In routine practice, however, the costs and benefits of both proce-
dures should be taken into account. Some health service providers,
particularly under the public health system, face difficulties ac-
quiring endoscopic gastrostomy apparatus due to their high cost.
Possible reasons for the current state of the research in this area
include the high cost of the procedures in question. Corry 2008
provided an example of this stating that the “cost of each feeding
tube is $26 for a NGT and $110 for a PEG tube” However, it is
noteworthy that because nasogastric tubes are easier to introduce
(more often by the nursing team) and less weight is placed on the
cost of constantly changing them as stated in Corry 2008 “The
insertion costs are significantly different as the NGT are inserted
by nursing staff in outpatients and the PEG tubes are inserted by
surgeons in theatre. The cost for insertion of a NGT is $50 (in-
cludes nursing time and cost of chest X-ray), whereas the cost of
insertion of a PEG tube is $626”. Therefore endoscopic gastros-
tomies may be less frequently indicated (Corry 2008).
It is important to note that in clinical practice, an endoscopic ex-
amination performed prior to PEG insertion is indicated in all
cases, as the patient might present with lesions of the gastroin-
testinal tract, which prevents the passage of the endoscopy device
and even tubes. In such patients, gastric tumours might also be
present, which precludes gastrostomy. Partial gastric resections can
also influence patients to elect to use alternative methods of enteral
feeding.
Implications for research
Our systematic review of the current evidence, carried out in 2014,
indicated that information is available on important outcomes
such as intervention failure, mortality, pneumonia and adverse
events. The included studies were carried out with participants
with varying baseline diseases including neurological baseline dis-
eases and those with malignancies. Future studies should provide
adequate baseline information such as baseline disease, gender and
age of the participants. The gastrostomy technique was described
only in some of the included studies, and future researchers should
ideally specify the technique used and the experience of the pro-
fessionals involved to allow for the analysis of more specific sub-
groups. Data on the nutritional status of the patients would prove
valuable, as would a cost/benefit analysis of the number of feeding
tubes used. Quality-of-life measures provide useful information
about patient important outcomes and may help explain differ-
ences in adherence to treatment.
The high cost of the procedures in question combined with the
difficulties associated with the randomisation and long-term fol-
low-up of patients and explain why the majority of studies exam-
ine a small number of participants. Nevertheless, we believe that
further randomised clinical trials should be conducted with rig-
orous observation of internal validity. They should also include
previously planned and executed follow-up periods.
A C K N OW L E D G E M E N T S
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Baeten 1992
Methods Single-centre parallel randomised controlled trial
Setting: 1 hospital in the Netherlands
Sample size: not reported
Participants Ninety patients with neurologic problems, ear, nose and throat tumours and surgical
problems. 56 male, 34 female; mean age 72 (62 to 82)
Inclusion criteria: indication for enteral nutrition
Exclusion criteria: contra-indication for either method
Interventions PEG (n = 44) - Freka set (Fresenius)
NGT (n = 46) -silicone tube 14 inch inserted by nurse
Outcomes 1. Mortality
2. Treatment failures
3. Adverse events
4. Pneumonia
5. Patient convenience (5-point graded scale from 1 = very convenient to 5 = very
inconvenient)
6. Nurse convenience (5-point graded scale from 1 = very convenient to 5 = very
inconvenient)
7. Time for enteral nutrition (days)
8. Time for insertion (minutes)
Notes Follow-up: mean nutrition time 17.9 ± 19.9 days
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Low risk Sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible for this type of intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcome assessors not blinded as explicitly
referred by the authors
Incomplete outcome data (attrition bias)
All outcomes
Low risk There were no withdrawals reported by the
study investigators
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Baeten 1992 (Continued)
Selective reporting (reporting bias) Low risk Relevant outcomes analysed
Other bias High risk Follow-up was not previously established
Bath 1997
Methods Single-centre parallel randomised controlled trial
Setting: 1 hospital in UK
Sample size: not reported
Participants Nineteen patients (8 male, 11 female); mean age: 77 years (11)
Baseline disease: 13 Ischaemic stroke, six haemorrhagic stroke
Inclusion criteria: stroke within two weeks of stroke onset
Exclusion criteria: oro-gastrointestinal disease concurrent severe illness, coagulopathy,
pre-morbid dependency, severe dementia, psychiatric illness
Interventions PEG: details not available
NGT: details not available
Outcomes Primary outcomes
1. Resumption of safe feeding at 12 weeks
2. Weight loss < 5% at 6 weeks
3. Discharge by 6 weeks
Secondary outcomes
1. Impairment
2. Disability
3. Handicap
4. Quality of life
5. Tube failures
6. Chest infection
7. Oropharyngeal delay time at 4 weeks
Notes Follow-up: three months
Risks of bias was judged from a systematic review previously published by the author
(Bath 2009) and by email contact with the author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated by minimisation
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible for this type of intervention
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Bath 1997 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not explicitly stated to be blinded by the
study investigators
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat analysis
Selective reporting (reporting bias) Low risk Relevant outcomes were analysed
Other bias High risk Unpublished study
Corry 2008
Methods Parallel randomised controlled trial
Setting: hospitals in Australia; enteral feeding on an outpatient basis
Sample size: the study planned to recruit 150patients over two years, allowing a difference
of at least 1.4 kg in mean weight loss to be detected between the two feeding tubes with
80% power using a two-sided test with significance level of 5%
Participants 42 patients; 24 male, 9 female; median age 60 (46 to 80)
Inclusion criteria: patients with squamous cell carcinoma of the head and neck planned
for curative radiotherapy or chemoradiation who were anticipated to require enteral
feeding
Exclusion criteria: refusal to be randomised and refusal to receive any tube for nutrition
Interventions PEG (n = 22); push technique by Tucker (Kimberley-Clark MIC e Wilson-Cook)
NGT (n = 20); fine bore tube inserted by nurse and confirmed the correct placement by
a chest X-ray and aspiration of stomach contents
All patients received enteral feeding at home
Outcomes 1. Nutritional status (weight, upper-arm circumference, triceps skin fold thickness)
2. Duration of enteral feeding
3. Complication
4. Patient satisfaction (modified QoL questionnaire)
5. Costs
All patients were assessed 6 months post-treatment
Notes Nine patients did not receive the intervention to which they were allocated
Outcome four was not considered for analysis because the instrument of evaluation is
not formally validated
Outcome one was not suitable for analysis because it was not explicitly informed if they
were reported as means or medians
Risk of bias
Bias Authors’ judgement Support for judgement
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Corry 2008 (Continued)
Random sequence generation (selection
bias)
Low risk Adaptive biased coin technique
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible for this type of intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcome assessors not blinded as explicitly
referred by the authors
Incomplete outcome data (attrition bias)
All outcomes
Low risk Flow of patients was clearly reported
Selective reporting (reporting bias) Low risk Relevant outcomes were analysed
Other bias Low risk None suspected
Dennis 2005
Methods Multicentric parallel randomised controlled trial
Setting: multicentric study involving many countries, mainly UK
Sample size: 1000 patients based on 85% power to detected and absolute risk difference
for death or poor outcome of 9%. Type one error: 0.05
Participants 321 patients: 144 male, 177 female; mean age 76 (10); dysphagic stroke patients
Inclusion criteria: recent stroke (within 7 days before admission), first-ever or recurrent,
if the responsible clinician was uncertain of the best feeding (PEG or NGT)
Exclusion criteria: patients with subarachnoid haemorrhage
Interventions PEG (n = 162)
NGT (n = 159)
Outcomes 1. Mortality or poor outcome
2. Overall survival
3. Utility score (EUROQoL)
4. Quality of life (EUROQoL)
5. Length of hospital stay
6. Adverse events in hospital stay
7. Pneumonia
8. Causes of death
9. Treatment effect
10. Number of tubes inserted
11. Reasons for stopping feeding
12. Vital status
13. Functional ability (Modified Rankin scale)
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Dennis 2005 (Continued)
14. Clinicians’ satisfaction about enteral feeding
15. Time in enteral nutrition
Notes Follow-up: six months
Outcomes 3, 10 and 13 were not suitable for analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated, stratified by country,
age, gender, and predicted probability of
poor outcome (by minimisation)
Allocation concealment (selection bias) Low risk The randomisation systemswere housed on
a secure server with access permitted, via a
password. Participating centres were issued
with codes in order for them to access the
randomisation services (three separate nu-
merical codes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk According to the authors, “the randomising
clinician, the clinical team, and the patients
were not unaware to treatment allocation-
doing so would have been impossible”
Blinding of outcome assessment (detection
bias)
All outcomes
High risk According to the authors, “the randomis-
ing clinician, the clinical team, and the pa-
tients were not unaware to treatment al-
location- doing so would have been im-
possible”. However, 6 month of follow-up
was carried out for the following variables:
patients’ vital status, functionalability with
themodified Rankin score (MRS), 19 place
of residence, method of feeding, and qual-
ity of life with the EUROQoL. For these
variables, the authors referred that “fol-
low-up was masked to treatment allocation
(except where patients or carers inadver-
tently unmasked an interviewer at follow-
up; such occurrenceswere unusual but their
frequency was not systematically recorded)
”
Because of these divergences the study was
considered as of high risk of bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Flow of patients was clearly reported
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Dennis 2005 (Continued)
Selective reporting (reporting bias) Low risk Relevant outcomes were analysed
Other bias Low risk None suspected
Douzinas 2006
Methods Single-centre parallel randomised controlled trial
Setting: 1 hospital (intensive care unit) in Greece
Sample size: not reported; pilot study was made
Participants 39 patients; 22 male, 14 female; median age: PEG 53 (20 to 82), NGT 58 (25 to 85)
Inclusion criteria: 1. patients on mechanical ventilation with NGT in place for more
than 10 days, suffering from persistent or recurrent ventilator-associated pneumonia and
reflux rate above 6%
Exclusion criteria: unstable haemodynamic state, administration of morphine, atropine,
theophylline, barbiturates, and cisapride, and a past history of GER or hiatal hernia.
Interventions PEG (n = 19): pull technique
NGT (n = 20): fine bore 14
Outcomes 1. Investigate if long-standing presence of NGT for feeding is associated with
increased incidence of gastro-oesophageal reflux (GER)
2. Investigate if PEG combined with semi-recumbent position and avoidance of
gastric nutrient retention lead to decreased incidence of GER in mechanically-
ventilated patients
3. Mortality
4. Pneumonia
5. Adverse events
Notes Follow-up: 20 days
Three patients randomly allocated to receive PEG were excluded because of hiatal hernia
(2) and intestinal bloating
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible for this type of intervention
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Douzinas 2006 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not explicitly stated by the study investi-
gators
Incomplete outcome data (attrition bias)
All outcomes
Low risk Flow of patients was clearly reported
Selective reporting (reporting bias) Low risk Relevant outcomes were analysed
Other bias Low risk None suspected
Elbadawy 2014
Methods Single-centre parallel randomised controlled 3-arm trial
Setting: Department of Critical Care Medicine, Egypt
Sample size; minimum sample size required was 20 patients for each group to achieve a
power of 80 % and alpha of 0.05
Participants 60 participants, with closed traumatic severe brain injury in need for prolongedMVwho
continued to have a Glasgow coma score (GCS) of less than 8 after initial stabiliSation
of their haemodynamic and oxygenation
Mean age not available.
Gender (male/female ratio):
NGT + intubation: 8/12
PEG + intubation: 9/11
PEG + tracheostomy: 11/9
Exclusion criteria:
History of known respiratory disease, thoracic trauma, multiple traumatic injuries in-
cluding abdominal or spinal trauma, massive or untreatable loculated ascites, previous
abdominal surgery, uncorrected coagulopathy
Interventions NGT+ intubation (n = 20): nasogastric tube and endotracheal tube was inserted through
which MV was applied
PEG + intubation (n = 20): PEG was done within 24 hours of endotracheal intubation
using percutaneous pull gastrostomy kit using Bard Ponsky pull through technique
PEG + tracheostomy (n = 20): percutaneous dilatational tracheostomy (PDT) and PEG
were done within 24 hours of endotracheal intubation
In all study groups, bolus enteral nutrition was given which was initiated within 24 hours
after intubation for patients in group (A) and 24 hours after performance of gastrostomy
for group (B and C). All the patients were nursed in a semi recumbent position (30-45o).
Proton pump inhibitor was given intravenously for stress ulcer prophylaxis (pantoprazole
40mg once daily) for each patient in all the study groups
Outcomes Primary
1. Intervention failures as defined by any event leading to failure to introduce the
tube, recurrent displacement and treatment interruption (feeding interruption,
blocking or leakage of the tube, no adherence to treatment).
Secondary
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Elbadawy 2014 (Continued)
1. Adverse events including ventilation assisted pneumonia
2. Duration of ICU stay.
3. Duration of mechanical ventilation
4. Duration of hospital stay.
5. Mortality rate of the patients
6. Vital signs
Adverse events including: infectionof tracheostomywound, bleeding from tracheostomy,
pneumothorax, tracheo-oesophageal fistula, infection of gastrostomy wound, GIT Fis-
tula, GIT Perforation, buried pumper syndrome (PEG tube erodes and migrates through
the gastric wall), paranasal sinusitis
Notes No statistically or clinically significant differences between comparison groups at base-
line for gender, mechanism of injury, characteristics based on computer tomography,
APACHE II score, Glasgow coma score, or other vital sign sand biochemical parameters
We combined data for the PEG + intubation and PEG + tracheostomy groups into a
single PEG group for comparison with NGT
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Described as randomised, consecutive
computer randomisation (further informa-
tion from study investigator)
Allocation concealment (selection bias) High risk Not concealed (further information from
study investigator)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible for this type of intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not explicitly stated by the study investi-
gators
Incomplete outcome data (attrition bias)
All outcomes
Low risk No attrition reported
Selective reporting (reporting bias) Low risk Relevant outcomes were analysed, protocol
not available for assessment
Other bias Low risk None
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Hamidon 2006
Methods Single-centre parallel randomised controlled trial
Setting: 1 hospital in Malaysia; patients were discharged in one or two days after the
intervention
Sample size: not reported
Participants 23 patients; 11 male, 11 female; median age: PEG 65 (48 to 79), NGT 72 (54 to 77)
Inclusion criteria: patients with acute Ischaemic stroke and persistent dysphagia for seven
or more days
Exclusion criteria: not related
Interventions PEG (n = 10): pull technique, Wilson CooK silicone tube 24 FR, inserted by a doctor
NGT (n = 12): Steril Cathline polyurethane tube, size 14 inserted by a nurse and checked
by aspirating asteric contents
Outcomes 1. Nutritional status assessed by recording anthropometric parameters and
nutritional markers
2. Treatment failure
Notes There was one dropout because it was impossible to contact the patient after four weeks
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random table
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible for this type of intervention;
although only surgeons were responsible
for the PEG and nurses by the NGT
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Information given by the patients by tele-
phone, but blinding of outcome assessment
was not explicitly stated by the study inves-
tigators
Incomplete outcome data (attrition bias)
All outcomes
Low risk Flow of patients was clearly reported (1
dropout due to failure to turn-up)
Selective reporting (reporting bias) Low risk Relevant outcomes were analysed
Other bias Low risk None suspected
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Norton 1996
Methods Parallel randomised controlled trial
Setting: 1 university hospital and one district general hospital in UK
Sample size: not reported
Participants 30 patients: 11 male, 19 female; mean age 77
Inclusion criteria: acute cerebrovascular accident with persisting dysphagia for eight or
more days, in need for sedation and prolonged mechanical ventilation
Exclusion criteria: patients with a previous history of gastrointestinal disease whichwould
preclude siting a gastrostomy tube or whowere unfit for upper gastrointestinal endoscopy
and IV sedation
Interventions PEG (n = 16): pull technique, Wilson Cook tube 24 FR or 12 FR Fresenius
NGT (n = 14): fine bore tube Flocare 500, inserted by a senior nurse
Outcomes 1. Mortality
2. Treatment failure
3. Adverse events
4. Pneumonia
5. Amount of feed administered
6. Change in nutritional status
7. Length of hospital stay
Notes Follow-up: six weeks for main outcomes
For continuous data, results were not available for all patients
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Low risk Sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible for this type of intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not explicitly stated by the study investi-
gators
Incomplete outcome data (attrition bias)
All outcomes
Low risk Flow of patients was clearly reported
Selective reporting (reporting bias) Low risk Relevant outcomes were analysed
Other bias Low risk None suspected
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Park 1992
Methods Parallel randomised controlled trial
Setting: three teaching hospitals in Glasgow
Sample size: 40 patients was selected to detect a two-sided difference between the success
of gastrostomy feeding at 90% and NGT feeding at 40% with a power of 0.9 and
significance of 0.05
Participants 40 patients with neurological dysphagia, 22 male, 18 female; mean age: PEG 56, NGT
65
Inclusion criteria: longstanding (4 weeks or more) dysphagia due to neurological disease;
stablemedical conditionwith likely survival of at least onemonth; ability to communicate
verbally or in writing; and presence of a normal gastrointestinal tract
Exclusion criteria: dementia;mechanical lesions causing obstruction of the oesophagus or
stomach; active intra-abdominal inflammation including inflammatory bowel disease or
pancreatitis; history of partial gastrectomy, reflux oesophagitis, or intestinal obstruction;
and presence of ascites, notable hepatomegaly, severe obesity, coagulopathy, untreated
aspiration pneumonia, and major systemic disease including malignancy and respiratory,
liver, or renal failure
Interventions PEG (n = 20) Bard 20Fr silicone tube, technique by Ponsky - Gauderer
NGT (n = 20) fine bore Abbott Flexitube, polyurethane, 850mm length,1.5mm internal
diameter
Outcomes 1. Mortality
2. Duration of feeding (days)
3. Treatment failure
4. Adverse events
5. Pneumonia
6. Nutritional status (weight, albumin, mean difference weight, mid-arm muscle
circumference, triceps skin fold thickness)
7. Received/prescribed feed
Notes Outcome six was not considered for analysis because only one patient completed the
follow-up
Outcome seven was not considered clinically relevant by itself, unless it causes failure or
affects nutritional status (anthropometric parameters)
Follow-up: 28 days
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers
(Epistat Statistical Package)
Allocation concealment (selection bias) Low risk Sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible for this type of intervention
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Park 1992 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not explicitly stated by the study investi-
gators
Incomplete outcome data (attrition bias)
All outcomes
Low risk Flow of patients was clearly reported
Selective reporting (reporting bias) Low risk Relevant outcomes were analysed
Other bias High risk There was 95% (19/20) of dropouts in the
NGTgroup due to failures in the treatment
and death
Sadasivan 2012
Methods Single-centre parallel randomised controlled trial.
Sample size: a minimum of 40 cases in each group, with 80%- to -90% power and
95% confidence (80% on tube dislodgement and 90% on infection). So, 50 cases were
included in each group
Setting: India, Department of ENT (Ear, Nose, Throat; Otorhinolaryngology)
Participants 100 participants
Gender: PEG: 34/16 (male/female ratio); NGT: 33/17 (male/female ratio)
Age (mean): not reported
Inclusion criteria: patientswith advanced stage 2or 3 squamous cell carcinomaof the head
and neck and who were scheduled either for radical surgery with adjuvant radiotherapy
(RT), chemo-RT, or for concurrent chemo and radiation therapy were included in the
study
Exclusion criteria: patients with early stage 1 or 2 head and neck cancer were excluded
from the study
Interventions PEG n = 50; NGT n = 50
The majority of NG tubes were inserted by nurses, all PEG tubes were inserted by
gastroenterologists
Outcomes Follow-up: 1 week; 6 weeks and 6 month
Primary outcomes
1. Intervention failures as defined by any event leading to failure to introduce the
tube, recurrent displacement and treatment interruption (feeding interruption,
blocking or leakage of the tube, no adherence to treatment) (based on Norton 1996).
Secondary outcomes
1. Nutritional status, as measured by any validated instrument (such as upper-arm
skin fold thickness, mid-arm circumference, body weight, serum albumin level,
haemoglobin (Ramel 2008)).
2. Quality of life, EORTC QLQH& N35 at 6 weeks (Dorman 1997)): pain,
learning to use, inconvenience, uncomfortable feeds, altered body image, family life,
social activities.
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Sadasivan 2012 (Continued)
Notes Statistical differences at baseline: radical surgery and adjuvant radiotherapy or chemo and
radiation therapy (PEG: 92%; NGT: 72%; P = 0.01); concurrent chemo- and radiation
therapy (PEG: 8%; NGT: 28% P = 0.01); baseline weight: PEG: 56.5 versus NGT: 61
(P < 0.01)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported by the study investigators
Allocation concealment (selection bias) Unclear risk Not reported by the study investigators
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible for this type of intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported by the study investigators
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Study investigators did not perform ITT
analysis
Selective reporting (reporting bias) Low risk None suspected: relevant variables were
analysed. The protocol was not assessed
Other bias Unclear risk None suspected
Yata 2001
Methods Single-centre parallel randomised controlled trial.
Sample size: not reported
Setting: 1 hospital in Inagawa Town (Japan)
Participants 82 patients: 22 male, 60 female; mean age: PEG 75.1 (50 to 96), NGT 76.5 (38 to 93)
Inclusion criteria: dysphagic patients
Exclusion criteria: not reported
Interventions PEG n = 42
NGT n = 40
Outcomes 1. Nutrition status (albumin, haemoglobin and cholesterol)
2. Adverse events
3. Mean survival time
4. Pneumonia
5. Reflux oesophagitis
39Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Yata 2001 (Continued)
6. Anaemia
7. Peristomal leakage
8. Gastric ulcer
9. Treatment failure
Notes Study available only as a meeting abstract
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not possible for this type of intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not explicitly described by the study inves-
tigators
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Flow of patients was not clearly reported
Selective reporting (reporting bias) Low risk Relevant outcomes were analysed,
Outcome 7. was reported only for NGT
group
Outcomes 8 and 9 were reported only for
the PEG group
Other bias High risk Unpublished study
GER: gastroesophogeal reflux
ITT: intention-to-treat
IV: intravenous
NGT: nasogastric tube
PEG: percutaneous endoscopic gastrostomy
QoL: quality of life
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
McClave 2005 Retrospective study
Mekhail 2001 Randomised controlled trial with intervention out of interest for this review (patients randomised to stop the enteral
nutrition according to different residual gastric volume)
Schulz 2009 Retrospective study
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D A T A A N D A N A L Y S E S
Comparison 1. PEG versus NGT
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Intervention failure 8 408 Risk Ratio (M-H, Random, 95% CI) 0.18 [0.05, 0.59]
1.1 All baseline diseases 8 408 Risk Ratio (M-H, Random, 95% CI) 0.18 [0.05, 0.59]
2 Non adherence to treatment 1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Non adherence at 6 weeks 1 94 Risk Ratio (M-H, Random, 95% CI) 0.07 [0.00, 1.17]
2.2 ITT non adherence at 6
weeks
1 100 Risk Ratio (M-H, Random, 95% CI) 0.02 [0.00, 0.36]
2.3 ITT non adherence at 6
months
1 100 Risk Ratio (M-H, Random, 95% CI) 0.01 [0.00, 0.16]
3 Intervention failure (subgrouped
by gastrostomy technique)
8 408 Risk Ratio (M-H, Random, 95% CI) 0.18 [0.05, 0.59]
3.1 Pull technique 3 90 Risk Ratio (M-H, Random, 95% CI) 0.07 [0.01, 0.35]
3.2 Push technique 1 33 Risk Ratio (M-H, Random, 95% CI) 0.05 [0.00, 0.74]
3.3 Non-reported technique 4 285 Risk Ratio (M-H, Random, 95% CI) 0.43 [0.13, 1.44]
4 Intervention failure (subgrouped
by baseline disease)
8 408 Risk Ratio (M-H, Random, 95% CI) 0.18 [0.05, 0.59]
4.1 Cerebrovascular event or
neurological baseline diseases
4 109 Risk Ratio (M-H, Random, 95% CI) 0.08 [0.02, 0.33]
4.2 Mixed baseline diseases 4 299 Risk Ratio (M-H, Random, 95% CI) 0.32 [0.08, 1.32]
5 ITT analyses 5 Risk Ratio (M-H, Random, 95% CI) Subtotals only
5.1 ITT intervention failure
non-reported gastrostomy
technique
4 285 Risk Ratio (M-H, Random, 95% CI) 0.37 [0.09, 1.45]
5.2 ITT intervention failure
mixed baseline diseases
4 305 Risk Ratio (M-H, Random, 95% CI) 0.29 [0.06, 1.33]
6 Mortality irrespective of
follow-up time
9 644 Risk Ratio (M-H, Random, 95% CI) 0.86 [0.58, 1.28]
7 Mean survival (months) 1 82 Mean Difference (IV, Random, 95% CI) 4.30 [3.28, 5.32]
8 Adverse effects irrespective of
follow-up time
6 597 Risk Ratio (M-H, Random, 95% CI) 0.83 [0.51, 1.34]
8.1 Adverse effects 6 597 Risk Ratio (M-H, Random, 95% CI) 0.83 [0.51, 1.34]
9 Adverse effects irrespective of
follow-up time
6 603 Risk Ratio (M-H, Random, 95% CI) 0.81 [0.48, 1.35]
9.1 ITT adverse effects
irrespective of follow-up time
6 603 Risk Ratio (M-H, Random, 95% CI) 0.81 [0.48, 1.35]
10 Pneumonia irrespective of
follow-up time
7 645 Risk Ratio (M-H, Random, 95% CI) 0.70 [0.46, 1.06]
11 Reflux oesophagitis 1 82 Risk Ratio (M-H, Random, 95% CI) 0.45 [0.22, 0.92]
12 Weight kg (endpoint) 1 21 Mean Difference (IV, Random, 95% CI) 3.20 [-5.95, 12.35]
13 Weight (change from baseline) 3 148 Mean Difference (IV, Random, 95% CI) 3.11 [-0.52, 6.75]
14 Mid-arm circumference in cm
(endpoint)
2 Mean Difference (IV, Random, 95% CI) Subtotals only
14.1 Mid-arm circumference 2 54 Mean Difference (IV, Random, 95% CI) 1.58 [-0.11, 3.27]
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14.2 Sensitivity analysis 1 21 Mean Difference (IV, Random, 95% CI) 2.5 [-0.64, 5.64]
15 Mid-arm circumference in cm
(change from baseline)
2 115 Mean Difference (IV, Random, 95% CI) 1.16 [1.01, 1.31]
16 Albumin 2 Mean Difference (IV, Random, 95% CI) Subtotals only
16.1 Mean serum albumin
levels
2 107 Mean Difference (IV, Random, 95% CI) 6.03 [2.31, 9.74]
16.2 Sensitivity analysis 1 25 Mean Difference (IV, Random, 95% CI) 7.80 [5.52, 10.08]
17 Albumin (change from
baseline)
1 94 Mean Difference (IV, Random, 95% CI) 0.12 [0.11, 0.14]
18 Haemoglobin g/dL (change
from baseline)
1 94 Mean Difference (IV, Random, 95% CI) 0.59 [0.49, 0.69]
19 Score of patients satisfaction 1 43 Mean Difference (IV, Random, 95% CI) -0.56 [-1.32, 0.20]
20 Score of inconvenience by
nurses
1 68 Mean Difference (IV, Random, 95% CI) -0.58 [-1.18, 0.02]
21 Time on enteral nutrition
(days)
2 119 Mean Difference (IV, Random, 95% CI) 14.48 [-2.74, 31.71]
22 Quality of life measures
EORTC QLQ-H&N35
number scoring 3 or 4 (worst)
2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
22.1 Pain 2 133 Risk Ratio (M-H, Random, 95% CI) 0.33 [0.00, 471.74]
22.2 Learning to use 2 133 Risk Ratio (M-H, Random, 95% CI) 0.18 [0.00, 149.53]
22.3 Inconvenient 2 133 Risk Ratio (M-H, Random, 95% CI) 0.03 [0.00, 0.29]
22.4 Uncomfortable 2 133 Risk Ratio (M-H, Random, 95% CI) 0.03 [0.00, 0.29]
22.5 Altered/bad body image 2 133 Risk Ratio (M-H, Random, 95% CI) 0.01 [0.00, 0.18]
22.6 Family life 1 100 Risk Ratio (M-H, Random, 95% CI) 0.01 [0.00, 0.18]
22.7 Social activities 2 133 Risk Ratio (M-H, Random, 95% CI) 0.01 [0.00, 0.18]
23 Functional ability (MRS) 1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
23.1 MRS scale from 0-3 1 321 Risk Ratio (M-H, Random, 95% CI) 0.59 [0.34, 1.01]
23.2 MRS scale from 4-5 1 321 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.90, 1.61]
23.3 MRS scale from 4-5 or
death
1 321 Risk Ratio (M-H, Random, 95% CI) 1.10 [1.00, 1.20]
24 Length of hospital stay (days) 2 381 Mean Difference (IV, Random, 95% CI) -12.67 [-40.18, 14.
84]
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Analysis 1.1. Comparison 1 PEG versus NGT, Outcome 1 Intervention failure.
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 1 Intervention failure
Study or subgroup PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 All baseline diseases
Baeten 1992 10/44 11/46 19.9 % 0.95 [ 0.45, 2.01 ]
Bath 1997 0/10 3/9 9.9 % 0.13 [ 0.01, 2.22 ]
Corry 2008 0/15 12/18 10.2 % 0.05 [ 0.00, 0.74 ]
Hamidon 2006 0/10 5/12 10.1 % 0.11 [ 0.01, 1.73 ]
Norton 1996 0/16 3/14 9.7 % 0.13 [ 0.01, 2.25 ]
Park 1992 0/19 18/19 10.3 % 0.03 [ 0.00, 0.42 ]
Sadasivan 2012 0/50 16/44 10.1 % 0.03 [ 0.00, 0.43 ]
Yata 2001 9/42 11/40 19.8 % 0.78 [ 0.36, 1.68 ]
Total (95% CI) 206 202 100.0 % 0.18 [ 0.05, 0.59 ]
Total events: 19 (PEG), 79 (NGT)
Heterogeneity: Tau2 = 1.78; Chi2 = 26.11, df = 7 (P = 0.00048); I2 =73%
Test for overall effect: Z = 2.80 (P = 0.0050)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours PEG Favours NGT
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Analysis 1.2. Comparison 1 PEG versus NGT, Outcome 2 Non adherence to treatment.
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 2 Non adherence to treatment
Study or subgroup Favours PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Non adherence at 6 weeks
Sadasivan 2012 0/50 6/44 100.0 % 0.07 [ 0.00, 1.17 ]
Subtotal (95% CI) 50 44 100.0 % 0.07 [ 0.00, 1.17 ]
Total events: 0 (Favours PEG), 6 (NGT)
Heterogeneity: not applicable
Test for overall effect: Z = 1.85 (P = 0.064)
2 ITT non adherence at 6 weeks
Sadasivan 2012 0/50 22/50 100.0 % 0.02 [ 0.00, 0.36 ]
Subtotal (95% CI) 50 50 100.0 % 0.02 [ 0.00, 0.36 ]
Total events: 0 (Favours PEG), 22 (NGT)
Heterogeneity: not applicable
Test for overall effect: Z = 2.69 (P = 0.0072)
3 ITT non adherence at 6 months
Sadasivan 2012 0/50 50/50 100.0 % 0.01 [ 0.00, 0.16 ]
Subtotal (95% CI) 50 50 100.0 % 0.01 [ 0.00, 0.16 ]
Total events: 0 (Favours PEG), 50 (NGT)
Heterogeneity: not applicable
Test for overall effect: Z = 3.28 (P = 0.0010)
Test for subgroup differences: Chi2 = 0.91, df = 2 (P = 0.63), I2 =0.0%
0.001 0.01 0.1 1 10 100 1000
Favours PEG Favours NGT
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Analysis 1.3. Comparison 1 PEG versus NGT, Outcome 3 Intervention failure (subgrouped by gastrostomy
technique).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 3 Intervention failure (subgrouped by gastrostomy technique)
Study or subgroup Favours PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Pull technique
Hamidon 2006 0/10 5/12 10.1 % 0.11 [ 0.01, 1.73 ]
Norton 1996 0/16 3/14 9.7 % 0.13 [ 0.01, 2.25 ]
Park 1992 0/19 18/19 10.3 % 0.03 [ 0.00, 0.42 ]
Subtotal (95% CI) 45 45 30.1 % 0.07 [ 0.01, 0.35 ]
Total events: 0 (Favours PEG), 26 (NGT)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.79, df = 2 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 3.23 (P = 0.0013)
2 Push technique
Corry 2008 0/15 12/18 10.2 % 0.05 [ 0.00, 0.74 ]
Subtotal (95% CI) 15 18 10.2 % 0.05 [ 0.00, 0.74 ]
Total events: 0 (Favours PEG), 12 (NGT)
Heterogeneity: not applicable
Test for overall effect: Z = 2.17 (P = 0.030)
3 Non-reported technique
Baeten 1992 10/44 11/46 19.9 % 0.95 [ 0.45, 2.01 ]
Bath 1997 0/10 3/9 9.9 % 0.13 [ 0.01, 2.22 ]
Sadasivan 2012 0/50 16/44 10.1 % 0.03 [ 0.00, 0.43 ]
Yata 2001 9/42 11/40 19.8 % 0.78 [ 0.36, 1.68 ]
Subtotal (95% CI) 146 139 59.7 % 0.43 [ 0.13, 1.44 ]
Total events: 19 (Favours PEG), 41 (NGT)
Heterogeneity: Tau2 = 0.89; Chi2 = 10.14, df = 3 (P = 0.02); I2 =70%
Test for overall effect: Z = 1.37 (P = 0.17)
Total (95% CI) 206 202 100.0 % 0.18 [ 0.05, 0.59 ]
Total events: 19 (Favours PEG), 79 (NGT)
Heterogeneity: Tau2 = 1.78; Chi2 = 26.11, df = 7 (P = 0.00048); I2 =73%
Test for overall effect: Z = 2.80 (P = 0.0050)
Test for subgroup differences: Chi2 = 4.16, df = 2 (P = 0.12), I2 =52%
0.002 0.1 1 10 500
Favours PEG Favours NGT
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Analysis 1.4. Comparison 1 PEG versus NGT, Outcome 4 Intervention failure (subgrouped by baseline
disease).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 4 Intervention failure (subgrouped by baseline disease)
Study or subgroup PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Cerebrovascular event or neurological baseline diseases
Bath 1997 0/10 3/9 9.9 % 0.13 [ 0.01, 2.22 ]
Hamidon 2006 0/10 5/12 10.1 % 0.11 [ 0.01, 1.73 ]
Norton 1996 0/16 3/14 9.7 % 0.13 [ 0.01, 2.25 ]
Park 1992 0/19 18/19 10.3 % 0.03 [ 0.00, 0.42 ]
Subtotal (95% CI) 55 54 40.0 % 0.08 [ 0.02, 0.33 ]
Total events: 0 (PEG), 29 (NGT)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.96, df = 3 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 3.50 (P = 0.00046)
2 Mixed baseline diseases
Baeten 1992 10/44 11/46 19.9 % 0.95 [ 0.45, 2.01 ]
Corry 2008 0/15 12/18 10.2 % 0.05 [ 0.00, 0.74 ]
Sadasivan 2012 0/50 16/44 10.1 % 0.03 [ 0.00, 0.43 ]
Yata 2001 9/42 11/40 19.8 % 0.78 [ 0.36, 1.68 ]
Subtotal (95% CI) 151 148 60.0 % 0.32 [ 0.08, 1.32 ]
Total events: 19 (PEG), 50 (NGT)
Heterogeneity: Tau2 = 1.39; Chi2 = 14.25, df = 3 (P = 0.003); I2 =79%
Test for overall effect: Z = 1.58 (P = 0.12)
Total (95% CI) 206 202 100.0 % 0.18 [ 0.05, 0.59 ]
Total events: 19 (PEG), 79 (NGT)
Heterogeneity: Tau2 = 1.78; Chi2 = 26.11, df = 7 (P = 0.00048); I2 =73%
Test for overall effect: Z = 2.80 (P = 0.0050)
Test for subgroup differences: Chi2 = 1.79, df = 1 (P = 0.18), I2 =44%
0.001 0.01 0.1 1 10 100 1000
Favours PEG Favours NGT
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Analysis 1.5. Comparison 1 PEG versus NGT, Outcome 5 ITT analyses.
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 5 ITT analyses
Study or subgroup PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 ITT intervention failure non-reported gastrostomy technique
Baeten 1992 10/44 11/46 35.2 % 0.95 [ 0.45, 2.01 ]
Bath 1997 0/10 3/9 14.7 % 0.13 [ 0.01, 2.22 ]
Sadasivan 2012 0/50 22/44 15.1 % 0.02 [ 0.00, 0.31 ]
Yata 2001 9/42 11/40 35.0 % 0.78 [ 0.36, 1.68 ]
Subtotal (95% CI) 146 139 100.0 % 0.37 [ 0.09, 1.45 ]
Total events: 19 (PEG), 47 (NGT)
Heterogeneity: Tau2 = 1.25; Chi2 = 13.07, df = 3 (P = 0.004); I2 =77%
Test for overall effect: Z = 1.43 (P = 0.15)
2 ITT intervention failure mixed baseline diseases
Baeten 1992 10/44 11/46 33.5 % 0.95 [ 0.45, 2.01 ]
Corry 2008 0/15 12/18 16.6 % 0.05 [ 0.00, 0.74 ]
Sadasivan 2012 0/50 22/50 16.5 % 0.02 [ 0.00, 0.36 ]
Yata 2001 9/42 11/40 33.4 % 0.78 [ 0.36, 1.68 ]
Subtotal (95% CI) 151 154 100.0 % 0.29 [ 0.06, 1.33 ]
Total events: 19 (PEG), 56 (NGT)
Heterogeneity: Tau2 = 1.65; Chi2 = 16.37, df = 3 (P = 0.00095); I2 =82%
Test for overall effect: Z = 1.59 (P = 0.11)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.82), I2 =0.0%
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Analysis 1.6. Comparison 1 PEG versus NGT, Outcome 6 Mortality irrespective of follow-up time.
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 6 Mortality irrespective of follow-up time
Study or subgroup Favours PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Baeten 1992 13/41 5/42 11.6 % 2.66 [ 1.04, 6.80 ]
Bath 1997 6/10 6/9 16.6 % 0.90 [ 0.45, 1.79 ]
Corry 2008 0/15 0/18 Not estimable
Dennis 2005 79/162 76/159 29.4 % 1.02 [ 0.81, 1.28 ]
Douzinas 2006 3/16 5/20 7.5 % 0.75 [ 0.21, 2.67 ]
Elbadawy 2014 10/40 10/20 16.4 % 0.50 [ 0.25, 1.00 ]
Hamidon 2006 2/10 2/12 4.4 % 1.20 [ 0.20, 7.05 ]
Norton 1996 4/16 10/14 12.0 % 0.35 [ 0.14, 0.87 ]
Park 1992 1/20 1/20 2.0 % 1.00 [ 0.07, 14.90 ]
Total (95% CI) 330 314 100.0 % 0.86 [ 0.58, 1.28 ]
Total events: 118 (Favours PEG), 115 (NGT)
Heterogeneity: Tau2 = 0.13; Chi2 = 13.18, df = 7 (P = 0.07); I2 =47%
Test for overall effect: Z = 0.75 (P = 0.46)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 PEG versus NGT, Outcome 7 Mean survival (months).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 7 Mean survival (months)
Study or subgroup PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Yata 2001 42 11.4 (1.6) 40 7.1 (2.9) 100.0 % 4.30 [ 3.28, 5.32 ]
Total (95% CI) 42 40 100.0 % 4.30 [ 3.28, 5.32 ]
Heterogeneity: not applicable
Test for overall effect: Z = 8.26 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 PEG versus NGT, Outcome 8 Adverse effects irrespective of follow-up time.
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 8 Adverse effects irrespective of follow-up time
Study or subgroup PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Adverse effects
Baeten 1992 21/41 17/42 19.7 % 1.27 [ 0.79, 2.03 ]
Corry 2008 8/15 6/18 14.5 % 1.60 [ 0.71, 3.59 ]
Dennis 2005 56/162 59/159 22.3 % 0.93 [ 0.69, 1.25 ]
Douzinas 2006 16/16 20/20 23.9 % 1.00 [ 0.90, 1.11 ]
Norton 1996 4/16 6/14 11.4 % 0.58 [ 0.21, 1.65 ]
Sadasivan 2012 2/50 28/44 8.2 % 0.06 [ 0.02, 0.25 ]
Total (95% CI) 300 297 100.0 % 0.83 [ 0.51, 1.34 ]
Total events: 107 (PEG), 136 (NGT)
Heterogeneity: Tau2 = 0.25; Chi2 = 37.33, df = 5 (P<0.00001); I2 =87%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 PEG versus NGT, Outcome 9 Adverse effects irrespective of follow-up time.
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 9 Adverse effects irrespective of follow-up time
Study or subgroup PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 ITT adverse effects irrespective of follow-up time
Baeten 1992 21/41 17/42 19.5 % 1.27 [ 0.79, 2.03 ]
Corry 2008 8/15 6/18 14.9 % 1.60 [ 0.71, 3.59 ]
Dennis 2005 56/162 59/159 21.7 % 0.93 [ 0.69, 1.25 ]
Douzinas 2006 16/16 20/20 23.1 % 1.00 [ 0.90, 1.11 ]
Norton 1996 4/16 6/14 12.0 % 0.58 [ 0.21, 1.65 ]
Sadasivan 2012 2/50 34/50 8.9 % 0.06 [ 0.01, 0.23 ]
Total (95% CI) 300 303 100.0 % 0.81 [ 0.48, 1.35 ]
Total events: 107 (PEG), 142 (NGT)
Heterogeneity: Tau2 = 0.30; Chi2 = 43.56, df = 5 (P<0.00001); I2 =89%
Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 PEG versus NGT, Outcome 10 Pneumonia irrespective of follow-up time.
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 10 Pneumonia irrespective of follow-up time
Study or subgroup PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Baeten 1992 2/41 2/42 4.0 % 1.02 [ 0.15, 6.93 ]
Corry 2008 4/15 6/18 9.3 % 0.80 [ 0.28, 2.32 ]
Dennis 2005 56/162 59/159 21.2 % 0.93 [ 0.69, 1.25 ]
Douzinas 2006 16/16 20/20 23.3 % 1.00 [ 0.90, 1.11 ]
Elbadawy 2014 11/40 15/20 16.6 % 0.37 [ 0.21, 0.64 ]
Norton 1996 3/16 6/14 8.1 % 0.44 [ 0.13, 1.43 ]
Yata 2001 14/42 22/40 17.5 % 0.61 [ 0.36, 1.01 ]
Total (95% CI) 332 313 100.0 % 0.70 [ 0.46, 1.06 ]
Total events: 106 (PEG), 130 (NGT)
Heterogeneity: Tau2 = 0.19; Chi2 = 32.32, df = 6 (P = 0.00001); I2 =81%
Test for overall effect: Z = 1.67 (P = 0.095)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 PEG versus NGT, Outcome 11 Reflux oesophagitis.
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 11 Reflux oesophagitis
Study or subgroup PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Yata 2001 8/42 17/40 100.0 % 0.45 [ 0.22, 0.92 ]
Total (95% CI) 42 40 100.0 % 0.45 [ 0.22, 0.92 ]
Total events: 8 (PEG), 17 (NGT)
Heterogeneity: not applicable
Test for overall effect: Z = 2.18 (P = 0.029)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 PEG versus NGT, Outcome 12 Weight kg (endpoint).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 12 Weight kg (endpoint)
Study or subgroup PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Norton 1996 13 61 (11) 8 57.8 (10) 100.0 % 3.20 [ -5.95, 12.35 ]
Total (95% CI) 13 8 100.0 % 3.20 [ -5.95, 12.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 PEG versus NGT, Outcome 13 Weight (change from baseline).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 13 Weight (change from baseline)
Study or subgroup PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Corry 2008 15 -0.28 (2.1) 18 -0.32 (2.83) 35.4 % 0.04 [ -1.64, 1.72 ]
Norton 1996 13 2.2 (5.33) 8 -2.6 (3.93) 26.3 % 4.80 [ 0.82, 8.78 ]
Sadasivan 2012 50 -1.88 (0.59) 44 -6.68 (0.88) 38.3 % 4.80 [ 4.49, 5.11 ]
Total (95% CI) 78 70 100.0 % 3.11 [ -0.52, 6.75 ]
Heterogeneity: Tau2 = 8.97; Chi2 = 29.68, df = 2 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.68 (P = 0.093)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 PEG versus NGT, Outcome 14 Mid-arm circumference in cm (endpoint).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 14 Mid-arm circumference in cm (endpoint)
Study or subgroup PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Mid-arm circumference
Corry 2008 15 29.5 (2.93) 18 28.3 (2.93) 71.0 % 1.20 [ -0.81, 3.21 ]
Norton 1996 13 26.3 (5.3) 8 23.8 (1.8) 29.0 % 2.50 [ -0.64, 5.64 ]
Subtotal (95% CI) 28 26 100.0 % 1.58 [ -0.11, 3.27 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.47, df = 1 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 1.83 (P = 0.068)
2 Sensitivity analysis
Norton 1996 13 26.3 (5.3) 8 23.8 (1.8) 100.0 % 2.50 [ -0.64, 5.64 ]
Subtotal (95% CI) 13 8 100.0 % 2.50 [ -0.64, 5.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.56 (P = 0.12)
Test for subgroup differences: Chi2 = 0.26, df = 1 (P = 0.61), I2 =0.0%
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Analysis 1.15. Comparison 1 PEG versus NGT, Outcome 15 Mid-arm circumference in cm (change from
baseline).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 15 Mid-arm circumference in cm (change from baseline)
Study or subgroup PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Norton 1996 13 26.3 (5.3) 8 23.8 (1.8) 0.2 % 2.50 [ -0.64, 5.64 ]
Sadasivan 2012 50 -1.02 (0.14) 44 -2.18 (0.49) 99.8 % 1.16 [ 1.01, 1.31 ]
Total (95% CI) 63 52 100.0 % 1.16 [ 1.01, 1.31 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.70, df = 1 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 15.23 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.16. Comparison 1 PEG versus NGT, Outcome 16 Albumin.
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 16 Albumin
Study or subgroup PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Mean serum albumin levels
Norton 1996 15 30.1 (3.6) 10 22.3 (2.2) 53.3 % 7.80 [ 5.52, 10.08 ]
Yata 2001 42 36 (6.88) 40 32 (6.88) 46.7 % 4.00 [ 1.02, 6.98 ]
Subtotal (95% CI) 57 50 100.0 % 6.03 [ 2.31, 9.74 ]
Heterogeneity: Tau2 = 5.39; Chi2 = 3.95, df = 1 (P = 0.05); I2 =75%
Test for overall effect: Z = 3.18 (P = 0.0015)
2 Sensitivity analysis
Norton 1996 15 30.1 (3.6) 10 22.3 (2.2) 100.0 % 7.80 [ 5.52, 10.08 ]
Subtotal (95% CI) 15 10 100.0 % 7.80 [ 5.52, 10.08 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.72 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.64, df = 1 (P = 0.43), I2 =0.0%
-10 -5 0 5 10
Favours NGT Favours PEG
58Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.17. Comparison 1 PEG versus NGT, Outcome 17 Albumin (change from baseline).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 17 Albumin (change from baseline)
Study or subgroup PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Sadasivan 2012 50 -0.008 (0.03) 44 -0.13 (0.04) 100.0 % 0.12 [ 0.11, 0.14 ]
Total (95% CI) 50 44 100.0 % 0.12 [ 0.11, 0.14 ]
Heterogeneity: not applicable
Test for overall effect: Z = 16.55 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.18. Comparison 1 PEG versus NGT, Outcome 18 Haemoglobin g/dL (change from baseline).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 18 Haemoglobin g/dL (change from baseline)
Study or subgroup PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Sadasivan 2012 50 -0.14 (0.116) 44 -0.73 (0.32) 100.0 % 0.59 [ 0.49, 0.69 ]
Total (95% CI) 50 44 100.0 % 0.59 [ 0.49, 0.69 ]
Heterogeneity: not applicable
Test for overall effect: Z = 11.58 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.19. Comparison 1 PEG versus NGT, Outcome 19 Score of patients satisfaction.
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 19 Score of patients satisfaction
Study or subgroup PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Baeten 1992 22 1.77 (1) 21 2.33 (1.49) 100.0 % -0.56 [ -1.32, 0.20 ]
Total (95% CI) 22 21 100.0 % -0.56 [ -1.32, 0.20 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.44 (P = 0.15)
Test for subgroup differences: Not applicable
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Analysis 1.20. Comparison 1 PEG versus NGT, Outcome 20 Score of inconvenience by nurses.
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 20 Score of inconvenience by nurses
Study or subgroup PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Baeten 1992 38 2 (1.12) 30 2.58 (1.35) 100.0 % -0.58 [ -1.18, 0.02 ]
Total (95% CI) 38 30 100.0 % -0.58 [ -1.18, 0.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.89 (P = 0.058)
Test for subgroup differences: Not applicable
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Analysis 1.21. Comparison 1 PEG versus NGT, Outcome 21 Time on enteral nutrition (days).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 21 Time on enteral nutrition (days)
Study or subgroup Favours PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Baeten 1992 41 21.6 (22.4) 42 16.4 (14.4) 47.2 % 5.20 [ -2.92, 13.32 ]
Park 1992 19 28 (0E-7) 17 5.2 (1.5) 52.8 % 22.80 [ 22.09, 23.51 ]
Total (95% CI) 60 59 100.0 % 14.48 [ -2.74, 31.71 ]
Heterogeneity: Tau2 = 146.23; Chi2 = 17.90, df = 1 (P = 0.00002); I2 =94%
Test for overall effect: Z = 1.65 (P = 0.099)
Test for subgroup differences: Not applicable
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Analysis 1.22. Comparison 1 PEG versus NGT, Outcome 22 Quality of life measures EORTC QLQ-H&N35
number scoring 3 or 4 (worst).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 22 Quality of life measures EORTC QLQ-H%N35 number scoring 3 or 4 (worst)
Study or subgroup PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Pain
Corry 2008 7/15 1/18 50.9 % 8.40 [ 1.16, 60.84 ]
Sadasivan 2012 0/50 44/50 49.1 % 0.01 [ 0.00, 0.18 ]
Subtotal (95% CI) 65 68 100.0 % 0.33 [ 0.00, 471.74 ]
Total events: 7 (PEG), 45 (NGT)
Heterogeneity: Tau2 = 26.09; Chi2 = 18.37, df = 1 (P = 0.00002); I2 =95%
Test for overall effect: Z = 0.30 (P = 0.76)
2 Learning to use
Corry 2008 4/15 2/18 51.4 % 2.40 [ 0.51, 11.34 ]
Sadasivan 2012 0/50 44/50 48.6 % 0.01 [ 0.00, 0.18 ]
Subtotal (95% CI) 65 68 100.0 % 0.18 [ 0.00, 149.53 ]
Total events: 4 (PEG), 46 (NGT)
Heterogeneity: Tau2 = 22.35; Chi2 = 18.12, df = 1 (P = 0.00002); I2 =94%
Test for overall effect: Z = 0.50 (P = 0.61)
3 Inconvenient
Corry 2008 0/15 6/18 49.5 % 0.09 [ 0.01, 1.50 ]
Sadasivan 2012 0/50 44/50 50.5 % 0.01 [ 0.00, 0.18 ]
Subtotal (95% CI) 65 68 100.0 % 0.03 [ 0.00, 0.29 ]
Total events: 0 (PEG), 50 (NGT)
Heterogeneity: Tau2 = 0.54; Chi2 = 1.27, df = 1 (P = 0.26); I2 =21%
Test for overall effect: Z = 3.05 (P = 0.0023)
4 Uncomfortable
Corry 2008 0/15 6/18 49.5 % 0.09 [ 0.01, 1.50 ]
Sadasivan 2012 0/50 44/50 50.5 % 0.01 [ 0.00, 0.18 ]
Subtotal (95% CI) 65 68 100.0 % 0.03 [ 0.00, 0.29 ]
Total events: 0 (PEG), 50 (NGT)
Heterogeneity: Tau2 = 0.54; Chi2 = 1.27, df = 1 (P = 0.26); I2 =21%
Test for overall effect: Z = 3.05 (P = 0.0023)
5 Altered/bad body image
Corry 2008 0/15 0/18 Not estimable
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(. . . Continued)
Study or subgroup PEG NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Sadasivan 2012 0/50 44/50 100.0 % 0.01 [ 0.00, 0.18 ]
Subtotal (95% CI) 65 68 100.0 % 0.01 [ 0.00, 0.18 ]
Total events: 0 (PEG), 44 (NGT)
Heterogeneity: not applicable
Test for overall effect: Z = 3.19 (P = 0.0014)
6 Family life
Sadasivan 2012 0/50 44/50 100.0 % 0.01 [ 0.00, 0.18 ]
Subtotal (95% CI) 50 50 100.0 % 0.01 [ 0.00, 0.18 ]
Total events: 0 (PEG), 44 (NGT)
Heterogeneity: not applicable
Test for overall effect: Z = 3.19 (P = 0.0014)
7 Social activities
Corry 2008 0/15 0/18 Not estimable
Sadasivan 2012 0/50 44/50 100.0 % 0.01 [ 0.00, 0.18 ]
Subtotal (95% CI) 65 68 100.0 % 0.01 [ 0.00, 0.18 ]
Total events: 0 (PEG), 44 (NGT)
Heterogeneity: not applicable
Test for overall effect: Z = 3.19 (P = 0.0014)
Test for subgroup differences: Chi2 = 1.78, df = 6 (P = 0.94), I2 =0.0%
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Analysis 1.23. Comparison 1 PEG versus NGT, Outcome 23 Functional ability (MRS).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 23 Functional ability (MRS)
Study or subgroup Experimental NGT Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 MRS scale from 0-3
Dennis 2005 18/162 30/159 100.0 % 0.59 [ 0.34, 1.01 ]
Subtotal (95% CI) 162 159 100.0 % 0.59 [ 0.34, 1.01 ]
Total events: 18 (Experimental), 30 (NGT)
Heterogeneity: not applicable
Test for overall effect: Z = 1.92 (P = 0.055)
2 MRS scale from 4-5
Dennis 2005 65/162 53/159 100.0 % 1.20 [ 0.90, 1.61 ]
Subtotal (95% CI) 162 159 100.0 % 1.20 [ 0.90, 1.61 ]
Total events: 65 (Experimental), 53 (NGT)
Heterogeneity: not applicable
Test for overall effect: Z = 1.26 (P = 0.21)
3 MRS scale from 4-5 or death
Dennis 2005 144/162 129/159 100.0 % 1.10 [ 1.00, 1.20 ]
Subtotal (95% CI) 162 159 100.0 % 1.10 [ 1.00, 1.20 ]
Total events: 144 (Experimental), 129 (NGT)
Heterogeneity: not applicable
Test for overall effect: Z = 1.93 (P = 0.053)
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Analysis 1.24. Comparison 1 PEG versus NGT, Outcome 24 Length of hospital stay (days).
Review: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Comparison: 1 PEG versus NGT
Outcome: 24 Length of hospital stay (days)
Study or subgroup PEG NGT
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Dennis 2005 162 55 (68) 159 53 (52) 47.8 % 2.00 [ -11.23, 15.23 ]
Elbadawy 2014 40 139.4 (17.19) 20 165.5 (7.98) 52.2 % -26.10 [ -32.47, -19.73 ]
Total (95% CI) 202 179 100.0 % -12.67 [ -40.18, 14.84 ]
Heterogeneity: Tau2 = 366.74; Chi2 = 14.07, df = 1 (P = 0.00018); I2 =93%
Test for overall effect: Z = 0.90 (P = 0.37)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours PEG Favours NGT
A D D I T I O N A L T A B L E S
Table 1. Continuous data unsuitable for inclusion in meta-analyses
Outcome PEG NGT P value Mean difference
(95% CI)
n n
mean albumin
(at 3 months)
(Yata 2001 ab-
stract)
3.6 42 3.2 40 < 0.01
mean albumin
(at 6 months)
(Yata 2001 ab-
stract)
3.1 42 3.9 40 < 0.01
mean hae-
moglobin (at 3
months) (Yata
2001 abstract)
11.7 42 11.9 40 no significant difference
mean hae-
moglobin (at 3
months) (Yata
11.1 42 12.4 40 no significant difference
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Table 1. Continuous data unsuitable for inclusion in meta-analyses (Continued)
2001 abstract)
median length
of stay (days) (
Dennis 2005)
34.0 (IQR 17 to
66)
162 37.0 (IQR 17 to 76) 159 not reported
utility
mean difference
between com-
parison groups
(endpoint)
Derived from
EuroQol be-
tween compari-
son groups (end-
point) favouring
NGT group, no
sta-
tistically signifi-
cant difference (
Dennis 2005)
0.12 0.035
(-0.024 to 0.093)
median patient
overall
quality of life at
first week (end-
point) (Corry
2008)
4.0
(R 2.0 to 7.0)
15 4.0
(R 2.0 to 7.0)
18 0.89
anthropo-
metric param-
eters (endpoint
medians) (
Hamidon 2006)
8 10
median TSFT
(mm)
20.1
(R 9.6 to 34)
12.7
(R 9.8 to 32)
0.076
median BSFT
(mm)
0.3
(R 4.8 to 13)
7.4
(R 4.4 to 15)
0.533
median MAC
(cm)
31.4
(R 22 to 36)
27.8
(R 21 to 37)
0.182
median serum
albumin (g/L)
39.5
(R 36 to 44)
36.0
(R 31 to 45)
0.045
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Table 1. Continuous data unsuitable for inclusion in meta-analyses (Continued)
median change
in gastro-
oesophageal re-
flux (%, end-
point) on day 7
(Douzinas 2006)
2.7
(R 0 to 10.4)
10.8
(R 6.3 to 36.6)
< 0.01
anthropomet-
ric parameters
(endpoint me-
dians) (6 weeks)
Corry 2008
up-
per-arm circum-
ference (mm) at
endpoint
302.5 (R 270 to
370)
15 300.0 (R 240 to
352)
18 0.69 Mean values stated in text
(Page 506) to be 295 vs. 283
mm P = 0.25
median TSFT
(mm)
13
(R 10 to 20)
15 12
(R 10 to 23)
18 0.65 The NGT patients had signif-
icantly
lower triceps skin fold thick-
ness (9.5 vs 13.5 mm; P = 0.
03) than the PEG patients at 6
weeks post-treatment
BSTF: biceps skin fold thickness
CI: confidence interval
IQR: interquartile range
MAC: mid-arm circumference
R: range
TSFT: triceps skin fold thickness
Table 2. Additional data of adverse events
Adverse
events
from
Elbadawy
2014
Group I
(NGT + intuba-
tion)
Group II
(PEG + intubation)
Group III
(PEG +
tracheostomy)
P1 P2 P3
No. % No. % No. %
Infection
of tra-
cheostomy
wound
0 0.0 0 0.0 16 80.00 - - -
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Table 2. Additional data of adverse events (Continued)
Bleeding
from tra-
cheostomy
0 0.0 0 0.0 0 0.00 - - -
Pneu-
mothorax
0 0.0 0 0.0 3 15.00 - - -
Tracheo-
oe-
sophageal
fistula
0 0.0 0 0.0 5 25.00 - - -
Infection
of gastros-
tomy
wound
0 0.0 10 50.00 9 45.00 - - 0.635
Leakage
around
gastros-
tomy tube
0 0.0 11 55.00 10 50 - - 0.732
Dislodge-
ment
of gastros-
tomy tube
0 0.0 10 50.00 9 45.00 - - 0.751
GIT
Fistula
0 0.0 0 0.00 0 0.00 - - -
GIT Per-
foration
0 0.0 0 0.00 0 0.00 - - -
Buried
Pumper
syndrome
0 0.0 0 0.00 0 0.00 - - -
Obstruc-
tion
0 0.0 1 5.00 1 0.00 - - 0.742
Paransal
sinusitis
12 60.0 0 0.0 0 0.0 - - -
P1 is the comparison between group I and group II
P2 is the comparison between group I and group III
P3 is comparison between group II and group III
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
1. esophag*
2. oesophag*
3. 1 or 2
4. disease*
5. Neoplasms/
6. cancer*
7. Adenocarcinoma/
8. or/4-7
9. 3 and 8
10. Pathologic Constriction
11. stenosis
12. stenoses
13. dysmotilit*
14. stricture
15. or/10-14
16. 3 and 15
17. (Esophageal Motility Disorders) or (Esophageal Diverticulum) or (Esophageal Diverticulosis) or (Esophageal Stenosis) or
(Esophageal Achalasia)
18. Deglutition Disorders/
19. dysphagia
20. swallowing disorder*
21. swallowing disturbance*
22. Esophageal Diseases/
23. or/16-22
24. Enteral Nutrition/
25. Gastrointestinal Intubation/
26. tube feeding
27. gastroenteral tube
28. nasoenteral tube
29. nasojejunal feeding tube
30. nasojejunal tube
31. enteral feeding
32. gastric feeding tube*
33. Feeding Apparatus/ or Nutritional Support/ or Enteric Feeding/ or Tube Feeding/
34. force feeding*
35. Nasogastric Tube/
36. post-pyloric feeding
37. postpyloric feeding
38. Enteric Feeding/
39. trans-pyloric feeding
40. nasoduodenal tube
41. Gastrointestinal Endoscopy/ or Digestive System Endoscopy/
42. endoscop*
43. Endoscopic Surgical Procedure*
44. Gastrostom*
45. Gastrostomy/
46. percutaneous endoscopic gastrostomy
47. or/24-46
48. (9 or 23) and 47
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Appendix 2. MEDLINE search strategy
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab.
5. clinical trials as topic.sh.
6. randomly.ab.
7. trial.ti.
8. or/1-7
9. (animals not (humans and animals)).sh.
10. 8 not 9
11. esophag$.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
12. oesophag$.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
13. 11 or 12
14. disease$.ab,ti.
15. exp Neoplasms/
16. cancer$.mp.
17. exp Adenocarcinoma/
18. or/14-17
19. 13 and 18
20. exp Constriction, Pathologic/
21. stenosis.mp.
22. stenoses.mp.
23. dysmotilit$.mp.
24. stricture.mp.
25. or/20-24
26. 13 and 25
27. Esophageal Motility Disorders/ or Diverticulum, Esophageal/ or Diverticulosis, Esophageal/ or Esophageal Stenosis/ or
Esophageal Achalasia/
28. exp Deglutition Disorders/
29. dysphagia.ab,ti.
30. swallowing disorder$.ab,ti.
31. swallowing disturbance$.ab,ti.
32. Esophageal Diseases/
33. or/26-32
34. exp Enteral Nutrition/
35. exp Intubation, Gastrointestinal/
36. tube feeding.ab,ti.
37. gastroenteral tube.ab,ti.
38. nasoenteral tube.ab,ti.
39. nasojejunal feeding tube.ab,ti.
40. nasojejunal tube.ab,ti.
41. enteral feeding.ab,ti.
42. gastric feeding tube$.ab,ti.
43. exp Feeding Apparatus/ or exp Nutritional Support/ or exp Enteric Feeding/ or exp Tube Feeding/
44. force feeding$.ab,ti.
45. Nasogastric Tube/
46. post-pyloric feeding.ab,ti.
47. postpyloric feeding.ab,ti.
48. Enteric Feeding/
49. trans-pyloric feeding.ab,ti.
50. nasoduodenal tube.ab,ti.
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51. exp Endoscopy, Gastrointestinal/ or exp Endoscopy, Digestive System/
52. endoscop$.ab,ti.
53. Endoscopic Surgical Procedure$.mp.
54. Gastrostom$.mp.
55. exp Gastrostomy/
56. percutaneous endoscopic gastrostomy.mp.
57. or/34-56
58. (19 or 33) and 57
59. 10 and 58
Appendix 3. EMBASE search strategy
1. (random$ or placebo$).ti,ab.
2. ((single$ or double$ or triple$ or treble$) and (blind$ or mask$)).ti,ab.
3. controlled clinical trial$.ti,ab.
4. RETRACTED ARTICLE/
5. or/1-4
6. (animal$ not human$).sh,hw.
7. 5 not 6
8. esophag$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug
manufacturer name]
9. oesophag$.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug
manufacturer name]
10. 8 or 9
11. disease$.ab,ti.
12. exp Neoplasms/
13. cancer$.mp.
14. exp Adenocarcinoma/
15. or/11-14
16. 10 and 15
17. exp Constriction, Pathologic/
18. stenosis.mp.
19. stenoses.mp.
20. dysmotilit$.mp.
21. stricture.mp.
22. or/17-21
23. 10 and 22
24. Esophageal Motility Disorders/ or Diverticulum, Esophageal/ or Diverticulosis, Esophageal/ or Esophageal Stenosis/ or
Esophageal Achalasia/
25. exp Deglutition Disorders/
26. dysphagia.ab,ti.
27. swallowing disorder$.ab,ti.
28. swallowing disturbance$.ab,ti.
29. Esophageal Diseases/
30. or/23-29
31. exp Enteral Nutrition/
32. exp Intubation, Gastrointestinal/
33. tube feeding.ab,ti.
34. gastroenteral tube.ab,ti.
35. nasoenteral tube.ab,ti.
36. nasojejunal feeding tube.ab,ti.
37. nasojejunal tube.ab,ti.
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38. enteral feeding.ab,ti.
39. gastric feeding tube$.ab,ti.
40. exp Feeding Apparatus/ or exp Nutritional Support/ or exp Enteric Feeding/ or exp Tube Feeding/
41. force feeding$.ab,ti.
42. Nasogastric Tube/
43. post-pyloric feeding.ab,ti.
44. postpyloric feeding.ab,ti.
45. Enteric Feeding/
46. trans-pyloric feeding.ab,ti.
47. nasoduodenal tube.ab,ti
48. exp Endoscopy, Gastrointestinal/ or exp Endoscopy, Digestive System/
49. endoscop$.ab,ti.
50. Endoscopic Surgical Procedure$.mp.
51. Gastrostom$.mp.
52. exp Gastrostomy/
53. percutaneous endoscopic gastrostomy.mp.
54. or/31-53
55. (16 or 30) and 54
56. 7 and 5
Appendix 4. LILACS search strategy
1. pt ensaio controlado aleatorio
2. pt ensaio clinico controlado
3. mh ensaios controlados aleatorios
4. mh distribuicao aleatoria
5. mh método duplo-cego
6. mh método simples-cego
7. pt estudo multicentrico
8. #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7
9. tw ensaio
10. tw ensayo
11. tw trial
12. #9 OR #10 OR #11
13. tw azar
14. tw acaso
15. tw placebo
16. tw control$
17. tw aleat$
18. tw random$
19. #13 OR #14 OR #15 OR #16 OR #17 OR #18
20. tw duplo
21. tw cego
22. #20 AND #21
23. tw doble
24. tw ciego
25. #23 AND #24
26. tw double
27. tw blind
28. #26 AND #27
29. #19 OR #22 OR #25 OR #28
30. tw clinic$
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31. #12 AND #29 AND #30
32. #8 OR #31
WH A T ’ S N E W
Last assessed as up-to-date: 30 July 2014.
Date Event Description
20 January 2015 New search has been performed New review author (CB), updated with news studies
and revised text to comply with current standards for
systematic review reporting
20 January 2015 New citation required but conclusions have not changed Updated with two new studies. Conclusions not
changed.
H I S T O R Y
Protocol first published: Issue 4, 2009
Review first published: Issue 11, 2010
Date Event Description
15 December 2011 New citation required but conclusions have not
changed
No new studies identified and conclusions unchanged.
15 December 2011 New search has been performed Literature searches rerun. No new studies identified
and conclusions unchanged
14 June 2011 Amended Information about number of studies were amended in
the Summary of Findings table and risk of bias termi-
nology updated with no change to overall assessments
C O N T R I B U T I O N S O F A U T H O R S
Conceiving the review: CG, JW and DM
Co-ordinating the review: CG
Screening search results: CG and SL
Organising retrieval of papers: CG and DRW
Screening retrieved papers against inclusion criteria: CG, SL, DM and JW with CB
Apraising quality of papers: CG, SL, RBA and DRW with CB
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Extracting data from papers: CG, DRW, SL and RBA with CB
Writing to authors of papers for additional information: CG with CB
Providing additional data about papers: CG with CB
Obtaining and screening data on unpublished studies: CG and DRW with CB
Data management for the review: CG and SL
Entering data into Review Manager (RevMan 5.0): CG and RBA, with CB
Other statistical analysis not using RevMan: RBA
Interpretation of data: CG,DM, SL,RBA and JW with CB
Statistical inferences: CG, RBA and SL
Writing the review: CG with CB
Person responsible for reading and checking review before submission: CG, DM, JW and SL
D E C L A R A T I O N S O F I N T E R E S T
None known.
Dr Cathy Bennett is the proprietor of Systematic Research Ltd and received a consultancy fee from the Cochrane UGPD group to
assist the authors with the update of their review in 2014.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• CAPES - Ministry of Education for the postgraduate scholarship, Brazil.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Previous criteria to evaluate the risk of bias are indicated below. The criteria were modified according to the new Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011)
Selection bias
• Was the allocation sequence adequately generated?
• Was allocation adequately concealed?
• Were there systematic differences between the baseline characteristics of the groups that were compared?
Attrition bias
Were there systematic differences between groups in withdrawals from a study?
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Detection bias
Were there systematic differences between groups in how outcomes were determined?
We included data in the analyses of scores of patient satisfaction and inconvenience to nursing staff from Baeten 1992, theses are five-
point scales and it is unclear if these were validated scales.
In this update, for mean values of outcome data with missing standard deviations, we calculated this from the difference between
means (Cochrane Handbook for Systematic Reviews of Interventions 7.7.3.3. Higgins 2011). We investigated the effects of making these
assumptions by performing sensitivity analyses where appropriate.
Outcomes
We report outcomes as specified in the protocol and clarify the following: pneumonia in this instance occurs as a direct result of
aspiration of food. Functional ability is included as an indicator of quality of life. Oesophageal reflux and reflux oesophagitis are adverse
effects. We have included survival time as an additional outcome grouped with mortality.
Data synthesis
We planned to pool continuous data using SMD, but where the units of measurement were the same we used MD.
Subgroup analyses
Wemade a post-hoc decision to investigate the possible reasons for heterogeneity in the intervention failure meta-analysis as we assumed
that the source of this statistical heterogeneity would be related to clinical heterogeneity. We categorised the studies by baseline disease,
i.e. cerebrovascular event or neurological disorder versusmixed baseline disease (i.e. participants whomay have had severe co-morbidities
including cancer).
I N D E X T E R M S
Medical Subject Headings (MeSH)
Deglutition Disorders [∗complications]; Enteral Nutrition [∗methods; mortality]; Gastrostomy [adverse effects; ∗methods; mortality];
Intubation, Gastrointestinal [adverse effects; methods; mortality]; Malnutrition [etiology; ∗therapy]; Pneumonia [etiology]; Random-
ized Controlled Trials as Topic; Treatment Failure
MeSH check words
Adult; Humans
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